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Experiment 1: An evaluation of the suitability of porcine lung tissue for human consumption 
This study was conducted to provide evidence of the safety of pork lungs for human 
consumption via an assessment of prevalence of potentially pathogenic bacteria and infectious 
agents. Specifically, the goal was to collect evidence that could be used to petition the current 
regulation disallowing use of pork lungs for human food. Pork lungs have been labeled by the 
U.S. Meat Export Federation as a widely consumed product across Asia as well as South and 
Central America. It was believed that there is profit potential in saving pork lungs and exporting 
them to specified countries. Pork lungs must first be deemed safe and edible before they can be 
sold on the export market. Lungs (N = 288) were collected from a total of six federally inspected 
young market barrow/gilt or sow processing facilities. In an attempt to obtain a representative 
sample of production at each facility on a given day, lungs were randomly selected throughout 
the entire production day. All collected lungs were removed and processed using aseptic 
techniques to prevent any exogenous contamination. Lung samples were tested for the presence 
of pathogens and other physical contamination. Lungs did not test positive for Yersinia spp., 
Influenza, or Mycobacterium spp., and they contained low yeast and mold counts. However, 
multiple lung samples collected from both barrows/gilts and mature sows tested positive for 
Salmonella spp., Shiga toxin-producing Escherichia coli, Campylobacter, and Streptococcus 
suis. Also, half of the samples collected were found to contain aspirated plant material within the 
iii 
 
airways of the lungs. These results suggested that pork lungs are not safe and should not be saved 
for human consumption. 
Experiment 2: Pork Fibrin used as a meat binder in pork variety and offal meats 
Fibrin is a cold set binding product that is created by recombining the two blood 
components of thrombin and fibrinogen. This study was conducted as a proof-of-concept to 
validate using fibrin derived from pork blood to create value-added export items from various 
pork offal and variety meats, hence adding value to both pork blood and pork offal/variety meats. 
Fibrin currently is marketed as Fibrimex® by Sonac, but the patent for producing fibrin expired 
leaving potential for U.S. pork operations to begin to produce their own fibrin and use it to create 
their own value-added products. A total of eight finished products were created in this study 
using Fibrimex® and pork offal/variety meats. Products for which use of the fibrin complex 
proved useful included a boneless baby back rib-like product made from pork jowl, a steak-like 
product made from diaphragms, a boneless hock, a log of skinned pork tongues, a pinwheel with 
pork diaphragm and cheese, a steak made from course ground heart and back fat, fresh bacon 
made from pork jowl, and a bung roll stuffed with liver, heart, and kidneys. These products were 
examples that demonstrated the binding capabilities of fibrin on offal/variety meats that differed 
in texture. All products were believed to have potential as successful export items. It was noted 
that fibrin could be added to many other meats to create additional products, including products 
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 Global pork trade, as expressed in dollar value, declined from 2014-2016, yet, U.S. pork 
exports have continued to increase over this period (USDA-FAS, 2015). The U.S. pork industry 
exported approximately 1.9 million tonnes of product in 2014; almost twice the amount exported 
in 2005 (1 million tonnes; USMEF, 2015). North American pork exports are projected to 
continue to grow and lead all other nations over the next ten years (OECD-FAO, 2014). 
However, the U.S. pork industry will need to continue to develop innovative ways to market 
their products in order to continue their impressive export growth rate. The U.S. pork industry 
can seek a competitive edge in exports by including new value-added products that are 
marketable in foreign countries through research conducted to determine ways to utilize products 
that are currently condemned at the time of slaughter.  
 By-products such as lungs, livers, brains, kidneys, blood, spleens, and tripe have a high 
nutritive value and are a major component of the diet in many foreign countries (Nollet and 
Toldra, 2011). Pork blood is a product that has been minimally utilized for edible purposes by 
slaughterhouses, with the majority of blood being converted to blood meal or dried for fertilizer. 
Blood has long been used as an ingredient in many foods such as blood sausages, soups, 
puddings, breads and crackers. Blood collected from slaughterhouses can be added to these 
products directly or be converted to other products for food as well. The primary purpose for 
adding blood or blood constituents to meat based products is to increase protein levels and 
enhance the water binding capabilities of that product (Mandal et al., 1999).  
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One product in particular, fibrin, is procured from blood components fibrinogen and 
thrombin and acts as a binder in restructured meat products. Fibrin acts a cold-set binding 
product that can be used with fresh meat. The first component is fibrinogen, which is a protein in 
blood, and the other component is thrombin, an enzyme from blood that acticates the binding 
process (Ryan et al., 1999; Barrett et al., 2004; Toldra et al., 2012). Fibrin naturally occurs when 
the protein fibrinogen is activated by the enzyme thrombin, thereby forming a strong bond of 
muscle tissue. Fibrin is effectively used in the meat and food industries to create value-added 
muscle foods. Fibrin currently is sold commercially in the U.S. as Fibrimex® by Sonac, a 
European company owned by Darling International. The patent held by Sonac for producing 
fibrin from blood has expired (Paardekooper and Wijngaards, 1986); therefore, it is reasonable to 
believe that U.S. pork operations could begin to collect blood at the time of slaughter and isolate 
fibrinogen and thrombin from blood in house to create fibrin. Ultimately, fibrin has potential as a 
binding agent to create novel items for export markets using variety meats and offal items. 
Lungs are another potential export item that remain relatively unexplored from an edibility 
standpoint. Results from a brief email survey to U.S. Meat Export Federation Regional Directors 
indicated that domestic and imported porcine and bovine lungs were consumed by humans in 
Asia as well as South and Central America. With the majority of international markets 
consuming porcine lungs, an enormous opportunity for exporting lungs into those markets may 
exist. However, United States Department of Agriculture’s Food Safety and Inspection Service 
(USDA-FSIS) regulations prohibit saving lungs from livestock for the purpose of human food. 
According to USDA-FSIS regulation, 9 CFR 310.16, livestock lungs “shall not be saved for 
human food”. This regulation became a final rule on June 17, 1971, and seemingly has not been 
disputed or explained since. In a separate document for “proposed rule making” dated December 
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31, 1969, further explanation of the reasoning behind not allowing lungs from livestock for 
human consumption was explained briefly. Other than the information provided in the 
aforementioned document, there is minimal, if any, explanation for deeming lungs inedible for 
humans. Specifically for pork, production practices have changed drastically over the past 40 
















 Meat binders have been used for many years to create innovative restructured products. 
Examples of products in which binding technologies are used include sectioned and formed 
hams, deli meats, sausages, emulsified meat products, and restructured intermediate value 
products. Products containing binders have grown in popularity due to variety, consistency of 
quality, convenience, and the economic preference for manufacturers to upgrade low-value raw 
meat cuts to higher-value products (Sheard, 2002). Binders help to create value-added meat 
products from valueless meat pieces or trim, and the capability of retaining moisture to increase 
yields makes them a technology that meat processors are becoming more attracted to and 
interested in given today’s high meat prices (Tsai et al., 1998). 
Binders that are added to meat products all have their own unique purpose and binding 
matrix which takes into account inclusion levels, pH, temperature, and type of meat they are 
added to. The two categories of binding agents include those that enhance the binding of pieces 
of meat and those that improve the water-binding capacity of the final product (Pearson and 
Gillett, 1996). Within these two categories of binding agents, there are two primary types of 
binders; thermal-set (hot-set) and chemical-set (cold-set) binders (Boles and Shand, 1999).  
Salt and phosphate are commonly used to extract salt-soluble proteins in restructured 
meat products to form emulsions and increase both the binding capability and water holding 
capacity of pieces of meat by thermally binding myofibrillar proteins that are extracted using an 
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agitation process such as massaging or tumbling (Schmidt and Trout, 1982; Pearson and Gillett, 
1996). Products using salt and phosphates to create a binder are primarily sold as ready-to-eat 
products (Boles and Shand, 1999). Other binders include raw egg whites, dried egg albumen, 
sodium caseinate, dried milk, soy protein, and food grade blood proteins; all bind via gel 
formation rather than by an extraction of salt-soluble myofibrillar proteins among meat pieces 
(Pearson and Gillett, 1996). Research reported here primarily focused on a cold-set binder 
referred to as fibrin, which uses blood proteins and enzymes that have gelation properties to 
enhance binding of meat to form restructured raw meat products (Ofori and Hsieh, 2011).  
Fibrin Formation 
 Fibrin is a cold-set binding agent that currently is marketed under the trademark name of 
Fibrimex® (Sonac). Fibrin is made by combining thrombin and fibrinogen, which are 
components of blood often isolated aseptically from cattle or swine at the time of slaughter 
(Toldra et al., 2012). Thrombin is a serine proteinase enzyme that is the final component of blood 
coagulation (Barrett et al., 2004). Fibrinogen is a blood protein that acts as the substrate for 
thrombin, and when combined together, the product fibrin is formed (Ryan et al., 1999).  
 The methodology for obtaining the two components was developed by the expired fibrin 
patent developers Paardekooper and Wijngaards (1986). Blood that is collected to retrieve 
thrombin and fibrinogen is initially stored at 4°C and then separated into blood cells and plasma. 
Plasma contains the thrombin which is separated by ion-exchange chromatography. A solution 
consisting of 0.2 M NaCl in 10mM of sodium citrate removes the unbound proteins. Remaining 
prothrombin is diluted 20 times in water and then activated by a meat thromboplastin from a 
meat extract in 0.6 M of calcium chloride. Final thrombin product used to make fibrin is frozen 
immediately and contains 20 NIH-U/ml of thrombin, 0.05 M NaCl, 0.5 mM sodium citrate, and 
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0.6M CaCl2. Fibrinogen also is collected from blood plasma; but, plasma is first frozen at -3°C 
and then melted to 0°C before fibrinogen can be separated via centrifuge. Partially-purified 
fibrinogen is then bagged and frozen immediately.  
Fibrin Application 
Fibrinogen and thrombin must remain frozen until they are used. Sealed containers 
containing the thrombin and fibrinogen are submerged in a 27°C water bath until completely 
thawed (Boles and Shand, 1999). A thrombin:fibrinogen ratio between 1:20 to 1:10 is added to 
the meat at an inclusion rate between 5% and 10% to initiate the binding process (Scientific 
Panel on Food Additives, Flavourings, Processing Aids, and Materials in Contact with Food, 
2005). The percentage of fibrin added to the meat largely depends on particle size. An increased 
surface area requires a greater percentage of fibrin (Paardekooper and Wijngaards, 1986). Fibrin 
forms cross-links with collagen which enables binding. Cross-linking occurs within 10-15 
minutes after addition and, therefore, must be mixed quickly (Boles, 2011). Binding occurs best 
when pH of meat is around 7.0 and the direction of the meat fibers run parallel (Boles and Shand, 
1998; Chen and Lin, 2002). Binding of formed product improves when an immediate vacuum is 
drawn to reduce air pockets that could prevent proper binding from occurring between meat 
pieces (Paardekooper and Wijngaards, 1986). Final product is then chilled at approximately 0°C 
for a minimum of 5 hours to allow bonding to proceed (Lennon et al., 2010). 
Fibrin Chemistry 
 A fibrin polymer results from the thrombin and fibrinogen reaction and is the primary 
clotting factor in whole blood (Weisel and Litvinov, 2013). A multiple-step reaction between 
fibrinogen and thrombin is required for the fibrin polymer to form which enables binding of 
meat. Fibrinogen is made up of two identical halves that each contain three distinct peptide 
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chains (Aα, B , and ) held together by disulfide bonds (Ryan et al., 1999). Thrombin is a 
plasma enzyme necessary for formation of fibrin. Thrombin cleaves the A and B fibrinopeptides 
from the fibrinogen and exposes the binding sites, called A and B, converting the molecule to 
fibrin (Mosesson, 2005; Rosenfeld et al., 2015). The binding sites interact with the ends of other 
fibrin molecules and the enzyme transglutaminase (found in the partially-purified fibrinogen) 
cross-links fibrin monomers to assemble in a half-staggered manner into two-stranded 
protofibrils. Fibrils then continue aggregating to form fibers that reach out into a three-
dimensional network. The fibrin network then cross-links with collagen to complete the binding 
process (Ryan et al., 1999; Lennon et al., 2010). 
Food Safety – Fibrin 
 The USDA-FSIS currently lists beef fibrin as a safe and acceptable food additive in the 
Food Standards and Labeling Policy Book (USDA-FSIS, 2005). Thrombin and fibrinogen are 
deemed safe because they are derived from edible animal parts. Blood collected from livestock 
that is to be used for human consumption must be collected aseptically and pass proper 
inspection protocols. There have been no known indications that blood fibrin added to food has 
an impact on allergic or intolerance response after consumption (Scientific Panel on Food 
Additives, Flavourings, Processing Aids, and Materials in Contact with Food, 2005). Fibrin is 
degraded by proteases and consequently should be degraded by the intestinal enzymes when 
consumed (Kolev et al., 1996; 1997). Thrombin is very unstable at high temperatures and low pH 
conditions and is therefore essentially eliminated from the final product after cooking and 





Effects of Fibrin on Meat Quality 
 Binders added to meat products have potential of changing slicing characteristics, flavor, 
color, protein levels, yield, and overall eating quality of meat products (Pearson and Gillett, 
1996). Each binding technology works differently based on ingredients and condition of the meat 
(Boles and Shand, 1999). In general, cold-set binders have been found to reduce issues regarding 
meat color and oxidative rancidity (Means and Schmidt, 1987; Raharjo et al., 1989). Cold-set 
bound products are often times more consumer-friendly because they can be utilized in a more 
versatile manner since they are often similar to fresh cuts of the same size (Esguerra, 1994).   
Addition of fibrin to meat products has multiple effects. Boles and Shand (1999) reported 
differences in color, multiple processing parameters, protein content, and sensory ratings when 
steakettes made from the two cold-set binders alginate and Fibrimex®  were compared. Steakettes 
manufactured with Fibrimex® had lower protein content and higher moisture content than 
steakettes made using alginate as a binder, which was expected given the fact that Fibrimex® is 
about 85% moisture. Consequently, steakettes bound by Fibrimex® were lower yielding, which 
also was observed by others (Chen and Trout, 1991; Esguerra, 1994; Boles and Shand, 1998). 
Steakettes made using Fibrimex® also had a higher bind strength and greater dimensional 
changes during cooking than steakettes made with alginate. These results differed from those of 
Esguerra (1994), who found that steakettes made from Fibrimex® had lower cooked bind 
strength. Steakettes manufactured using Fibrimex® were found to be redder in color than those 
bound with alginate. Finally, sensory panel ratings suggested that consumers found differences in 
juiciness, texture, and overall acceptability of Fibrimex® steakettes made from different cuts, but 





 Pork fibrin has the gelation properties necessary to enhance binding of pieces of meat to 
form restructured raw meat products (Ofori and Hsieh, 2011). Aseptic collection of pork blood 
opens up the opportunity for it to be centrifuged and separated into fibrinogen and thrombin, 
which can be combined to form fibrin (Paardekooper and Wijngaards, 1986; Toldra et al., 2012). 
Binding occurs when the fibrin network generated by the reaction between fibrinogen and 
thrombin cross-links with collagen of meat (Ryan et al., 1999; Lennon et al., 2010). Meat pieces 
can be successfully bound using a thrombin:fibrinogen ratio between 1:20 to 1:10 and an 
inclusion rate between 5% and 10% (Scientific Panel on Food Additives, Flavourings, 
Processing Aids, and Materials in Contact with Food, 2005). Fibrin was declared to be a safe and 
acceptable food additive by USDA-FSIS in the Food Standards and Labeling Policy Book 
(USDA-FSIS, 2005).  
Pork Lungs 
USDA Regulations on Livestock Lungs 
 In 1971, the USDA-FSIS declared that livestock lungs cannot be saved or used as human 
food (9 CFR 310.16). At this point, livestock lungs that are not condemned by USDA may be 
used in pet foods or other nonhuman foods (Post-Mortem Inspection, 1971). There has been very 
little research conducted addressing why lungs are considered inedible and what, if any, 
pathogens or debris reside within lung tissue. Lungs currently are consumed in foreign countries, 
which presents an opportunity to conduct more research on livestock lungs in order to determine 
whether or not the current regulation that prevents them from being saved for human food in the 





 The Centers for Disease Control and Prevention (CDC) estimated that approximately 1.2 
million illnesses and 450 deaths occur annually in the U.S from salmonellosis caused by 
Salmonella spp. (CDC, 2015a). Salmonella spp. are recognized as one of the most common 
causes of foodborne illness in humans, however, most cases caused by farm stock are associated 
with poultry (Rajic and Keenliside, 2001; Callaway et al., 2008). An estimated 8% of Salmonella 
cases in humans are associated with contaminated pork and pork products (IFSAC, 2015). 
Salmonella spp. have been found in the entire digestive track, lymphatic tissue, and stomach of 
swine (Mogstad, 1995). One study showed that 16 different Salmonella serotypes were found in 
fecal material of swine collected in the slaughter plant (Currier et al., 1986). The fact that 
Salmonella spp. are prevalent in swine makes it a critical pathogen that needs to be considered in 
research associated with pork products.  
Salmonella is considered a motile, non-sporeforming, Gram-negative, rod shaped bacteria 
that is found most readily in intestinal tracts of a host (Watson et al., 1995; Coburn et al., 2007; 
FDA, 2012a). The infective dose of Salmonella can be as few as one cell and it can cause either 
nontyphoidal salmonellosis or typhoid fever (FDA, 2012a). Salmonellosis is typically caused by 
oral ingestion of an infected product. Once consumed, Salmonella cells will pass from the 
intestinal tract into the epithelium, cause inflammation, and release potent enterotoxins and 
endotoxins (Aberlene et al., 2012; FDA 2012a). Symptoms of nontyphoidal salmonellosis 
usually last 4-7 days and include nausea, vomiting, abdominal cramps, diarrhea, fever, and 
headache (FDA, 2012a). Symptoms of typhoid fever will last 2-4 weeks and include high fever, 




Escherichia coli O157:H7/non-O157 STEC  
 Escherichia coli are bacteria often found in the digestive tract microflora of animals 
(CDC, 2015b). Most E. coli bacteria are harmless to humans, however, E. coli O157:H7 and six 
Shiga toxin-producing E. coli non-O157 serotypes (O26, O45, O103, O111, O121, and O145) 
are considered to be harmful pathogenic bacteria to humans (CDC, 2015b). The types of STEC 
found in different species varies. Harmful STEC has been found in swine excrement, including 
O26, O111, and O121 (Rios et al., 1999; Fratamico et al., 2004; Zweifel et al., 2006; Beutin et 
al., 2008). Swine are arguably the most similar to humans out of primary livestock species since 
they are monogastrics, and they tend to be more prone to disease caused by STEC (Bertschinger 
and Gyles, 1994; Gyles, 2007). The CDC calls E. coli O157:H7 one of the most common 
foodborne pathogens that causes illness in humans (CDC, 2015b). The E. coli O157:H7 outbreak 
that occurred from undercooked beef patties at Jack-in-the-Box restaurants in 1993 was perhaps 
the most famous food outbreak that the meat industry ever experienced and was the primary 
reason why it is the most concerning pathogen for all protein producers and packers (CDC, 
1993). Prevalence of E. coli O157:H7 in swine wasn’t actually documented in swine in the U.S. 
until 2003 (Feder et al., 2003). There is still limited research regarding how prevalent the six 
primary STEC and Escherichia coli O157:H7 are in swine products, including lungs. 
E. coli O157:H7 is classified as enterohemorrhagic Escherichia coli (EHEC). These 
serotypes of E. coli are Gram-negative, rod-shaped bacteria that produce Shiga toxins known to 
cause illness in humans (Paton and Paton, 1998; Bettelheim, 2003; FDA, 2012a; CDC, 2015b). 
The STEC route of entry is oral and once ingested, the bacteria attach to intestinal epithelial cells 
and produce Shiga toxins (stx) that pass into the bloodstream and become systemic (FDA, 
2012a). The infective dose for E. coli O157:H7 is typically in the range of 10 to 100 cells and the 
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infective dose for the other six disease causing STEC is considered to be slightly higher (FDA, 
2012a). Humans infected by STEC may experience hemorrhagic colitis, which is characterized 
by severe abdominal pain, nausea, and bloody diarrhea (FDA, 2012a). Hemorrhagic colitis has 
the potential to progress into haemolytic uremic syndrome (HUS) which occurs when toxin 
causes endothelial cell degeneration revealed by swelling which leads to thrombosis and acute 
renal failure (Tarr et al., 2005; Aberlene et al., 2012). Young children and elderly people are the 
most prone to developing HUS (Tarr et al., 2005; CDC, 2015b).  
Campylobacter spp. 
 Campylobacter spp. are found in the intestinal tract of animals and cause 
campylobacteriosis in humans (Altekruse et al., 1999; FDA, 2012a; CDC, 2015c). 
Campylobacter spp. have been estimated to cause 845,000 illnesses annually, which makes it the 
fourth most prevalent pathogen that contributes to human illness in the U.S. (CDC, 2011). 
Campylobacteriosis is most commonly associated with Campylobacter jejuni, which accounts 
for approximately 80% of reported cases (FDA, 2012a). Although Campylobacter jejuni is the 
most common Campylobacter cause of illness in humans, Campylobacter coli is the main 
species that has been isolated in swine and it presents the challenge of being more resistant to 
antimicrobial interventions (Bywater et al., 2004; Englen et al., 2005). Multiple studies on swine 
have shown that Campylobacter coli is much more prevalent in the gut and on the carcass of 
swine than Campylobacter jejuni (Mafu et al., 1989; Pearce et al., 2003; Farzan et al., 2009; 
Abley et al., 2011). Also, survival of Campylobacter jejuni outside of the host is poor when 
compared to Campylobacter jejuni (Ketley, 1997). Studies conducted on Campylobacter spp. in 
swine were encouraging from a public health point of view because Campylobacter coli was 
found to be the primary species in pork and not Campylobacter jejuni. 
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Campylobacter spp. are motile, spiral-shaped, non-sporeforming, and Gram-negative 
bacteria that thrive in warm environments with oxygen levels ranging from 3% to 5% (FDA, 
2012a; CDC, 2015c). Most Campylobacter spp. are fairly fragile and sensitive to freezing, 
drying, acidic conditions, and salinity (FDA, 2012a; CDC, 2015c). The pathogenesis of 
Campylobacter is fairly unknown, but research shows that if ingested, Campylobacter cells will 
cause infection by invading and colonizing the gastrointestinal tract (FDA, 2012a). The 
minimum infective dose of Campylobacter is estimated to be about 10,000 cells (FDA, 2012a). 
Humans who have been infected with Campylobacter have the possibility of contracting 
campylobacteriosis, or Campylobacter enteritis, which includes symptoms of fever, diarrhea, 
cramps, and vomiting that typically lasts two to ten days (FDA, 2012a). Children younger than 5 
years old and young adults 15 to 19 years old are the most prone to contracting 
campylobacteriosis (FDA, 2012a; CDC, 2015c). 
Yersinia spp. 
 Swine are a primary reservoir for Yersinia spp. that cause yersiniosis in humans (Funk et 
al., 1998). Undercooked pork that has been contaminated with Yersinia spp. is typically the 
source for humans who contract yersiniosis (FDA, 2012a). Yersinia spp. are primarily found in 
the lymph nodes but are also prevalent in the caecal content, tongues, and oral-pharyngeal fluid 
of swine (Lee et al., 1990; Bhaduri et al., 1997; Funk et al., 1998; Pujol and Bliska, 2004). 
Specific locations that Yersinia spp. are found within the animal makes the entire carcass prone 
to contamination if necessary processing techniques and interventions aren’t used appropriately.  
The three Yersinia spp. that are known to cause disease in humans are Yersinia enterocolitica, 
Yersinia pseudotuberculosis, and Yersinia pestis, however only the first two species mentioned 
are prevalent in swine (Funk et al., 1998; Pujol and Bliska, 2004; Bowman et al., 2007). 
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 Yersinia enterocolitica and Yersinia pseudotuberculosis are small, rod-shaped, Gram-
negative bacteria that have the ability to grow below 4°C and can survive freezing temperatures 
(FDA, 2012a). The average infective dose of pathogenic Yersinia spp. is believed to be between 
104 and 106 organisms (FDA, 2012a). Yersinia spp. that have infected a host, establish colonies 
within the lymphoid tissue, resist phagocytosis by neutrophils, and ultimately cause cytotoxic 
changes within the human cells (Pujol and Bliska, 2004; FDA, 2012a). Humans who have 
ingested Yersinia spp. are at risk for developing yersiniosis which causes diarrhea, fever, 
abdominal pain, and vomiting that lasts anywhere from three days to multiple weeks (FDA, 
2012a). Children under the age of 5 are the most prone to yersiniosis (FDA, 2012a). 
Staphylococcus aureus 
 The CDC reported approximately 241,000 foodborne illnesses were caused by 
staphylococcal food poising, which ranks Staphylococcus aureus as the fifth most prevalent 
pathogen contributing to foodborne illnesses in the United States (CDC, 2011). The pork 
industry has continually monitored and fought Staphylococcus aureus because ham and other 
pork products are frequently identified as the primary source of staphylococcal food poisoning 
(Bryan, 1988). Recently, the pork industry has focused specifically on methicillin-resistant 
Staphylococcus aureus (MRSA) (de Boer et al., 2009; Smith et al., 2009; Weese et al., 2010). 
The MRSA bacteria are resistant to methicillin which is commonly used to treat staphylococcal 
illness (de Boer et al., 2009). In an EU study conducted by de Neeling et al. (2007) a high 
prevalence of MRSA was found in pigs from farms and cross contamination occurred within the 
slaughterhouse. Research shows that swine are premium reservoirs for Staphylococcus aureus 




 Staphylococcus spp. are Gram-positive, non-motile, spherical, and catalase-positive 
bacteria that produce a highly heat-stable enterotoxin (FDA, 2012a). The enterotoxins produced 
by the bacteria can cause gastroenteritis, staphylococcal food poisoning, toxic shock syndrome, 
pneumonia, postoperative wound infection, and nosocomial bacteremia in humans (FDA, 2012a; 
CDC, 2015d). Staphylococcus spp. are very stable bacteria that can grow and survive extended 
periods in a dry state, in the temperature range of 7°C to 47.8°C, and in a pH range between 4.5 
and 9.3 (FDA, 2012a). The toxic dose is typically less than 1 microgram of enterotoxins, which 
is typically found in foods that exceed 100,000 Staphylococcal aureus organisms per gram 
(FDA, 2012a). Symptoms of staphylococcal food poisoning can develop within an hour after 
consumption and typically last less than a day (FDA, 2012a; CDC, 2015d). Anyone who 
consumes an infective dose of staphylococcal enterotoxins is at risk of experiencing the 
symptoms of staphylococcal food poisoning (FDA, 2012a). 
Streptococcus suis 
 Streptococcus suis is one of the most critical swine pathogens in the world. Research 
regarding Streptococcus suis has recently increased dramatically after a major outbreak occurred 
in China in 2005 where 204 people were infected and 38 of them died (Lun et al., 2007; 
Gottschalk et al., 2007; Fittipaldi et al., 2012). A total of 35 serotypes of Streptococcus suis have 
been discovered, however, serotype 2 is considered to be the most virulent and frequently 
isolated in both swine and humans (Gottschalk et al., 2007; Lun et al., 2007). Pathogenic 
Streptococcus suis is primarily isolated in the upper respiratory tract of infected swine, 
particularly the tonsils and nasal cavities (Higgins and Gottschalk, 1999). It also is important to 
note that Streptococcus suis is almost constantly present in the lungs of swine, but current 
regulations prevent the lungs from being saved for human consumption (Gottschalk and Segura, 
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2000). Recent research regarding Streptococcus suis in swine, especially results discovered by 
Gottschalk and Segura (2000), appeared to show that presence of Streptococcus suis in pork 
lungs is inevitable. 
 Streptococcus suis is a Gram-positive facultative anaerobe that is coccoid shaped (Lun et 
al., 2007; FDA, 2012a). The organism is very stable in both wet and dry environments at 0°C and 
it is able to grow in either aerobic or anaerobic conditions (Lun et al., 2007). Streptococcus suis 
is a zoonotic bacteria that can be transmitted to humans who come in close contact with infected 
swine or those who consume undercooked infected pork products (Lun et al., 2007; Gottschalk et 
al., 2007; Fittipaldi et al., 2012). Streptococcal infection occurs when Streptococcus suis 
colonizes the host, penetrates epithelial cells, survives in the bloodstream, and finally invades 
organs causing inflammation (Fittipaldi et al., 2012). Humans who experience streptococcal 
infections are likely to develop meningitis, but there have been cases of septic shock leading to 
organ failure, endocarditis, pneumonia, peritonitis, and arthritis (Lun et al., 2007).  
Mycobacterium spp. 
 Certain Mycobacterium spp. have been known to cause tuberculosis, which is responsible 
for approximately 1.7 million deaths annually throughout the world (CSIS, 2015). Fortunately, 
tuberculosis is rare in the U.S. and there are only an estimated 60 cases annually, primarily 
caused by unpasteurized milk (FDA, 2012a). Swine, however, are a primary host species in 
many other countries where tuberculosis is one of the deadliest infectious diseases (Bolin et al., 
1997; Straw et al., 2006; Alvarez et al., 2010; Lara et al., 2011). Swine that are infected with 
Mycobacterium spp. and that have developed tuberculosis generally develop granulomas in the 
lungs and lymph nodes (Bolin et al., 1997). The primary species groups responsible for causing 
disease belong to the Mycobacterium tuberculosis complex and the Mycobacterium avium 
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complex (Muwonge, 2012). The Mycobacterium tuberculosis complex includes species, such as 
Mycobacterium bovis, that are considered highly pathogenic and can cause tuberculosis 
(Muwonge, 2012). The Mycobacterium avium complex includes species that are typically non-
pathogenic and do not cause tuberculosis in humans, but can cause pulmonary disease, 
lymphadenitis, or infections in immunocompromised people (Muwonge, 2012). Both the 
Mycobacterium avium complex and the Mycobacterium tuberculosis complex are prevalent in 
swine raised in many foreign countries. 
 Mycobacterium spp. are Gram-positive, aerobic, non-motile, rod-shaped bacteria that 
lack an outer cell membrane (FDA, 2012a). Mycobacterium spp. have unique cell walls that 
enable them to survive exposure to caustic cleaners and resist lysis by antibiotics (FDA, 2012a). 
The organism is slow growing and most commonly found in water, soil, and bedding (FDA, 
2012a). The organism is often found within the lungs, lymph nodes, and gastrointestinal tracts of 
livestock and humans who are infected with Mycobacterium spp. (FDA, 2012a). The toxic dose 
for Mycobacterium tuberculosis is estimated to be less than 10 bacilli, but the toxic dose for 
Mycobacterium avium is unknown. Humans who have been infected with tuberculosis causing 
Mycobacterium spp. generally do not show symptoms until months after the initial infection 
(FDA, 2012a; CDC, 2015e). Everyone is susceptible to infection from species belonging to the 
Mycobacterium tuberculosis complex and generally only people who are severely 
immunocompromised are at risk of developing infection from organisms belonging to the 
Mycobacterium avium complex (FDA, 2012a). 
Type A Influenza H1N1 (Swine Flu) 
 The influenza A (H1N1) virus outbreak that began in 2009 is considered to be one of the 
greatest pandemic threats since the outbreak of influenza A (H3N2) that occurred in 1968 (Novel 
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Swine-Origin Influenza A [H1N1] Virus Investigation Team, 2009). It was estimated that 
influenza A (H1N1) was responsible for 60.8 million cases, 274,304 hospitalizations, and 12,469 
deaths that occurred in the U.S. between April 2009 and April 2010 (Shrestha et al., 2011). 
Influenza H1N1 is commonly referred to as swine flu because the first case discovered was 
similar to the virus found in pigs (Myers et al., 2006). Influenza H1N1 also is zoonotic and can 
be transferred from humans to swine or from swine to humans (Myers et al., 2006). Swine serve 
as reservoirs for the generation of reassortant viruses that may be more virulent and can transmit 
easier to humans than the parental influenza A viruses because they are found to be susceptible 
to infection with avian, swine, and human influenza viruses (Brown, 2000; Liu et al., 2011). It is 
important to note that consumers cannot contract the influenza H1N1 virus from eating properly 
cooked pork, which was a costly misperception the pork industry had to face in the wake of the 
2009 outbreak. 
 Swine flu is a respiratory disease caused by influenza A viruses, such as influenza H1N1, 
which is present in pigs (APHIS, 2013). Influenza A viruses tend to thrive in large confinement 
operations with limited ventilation (Myers et al., 2006). Swine and humans infected with 
influenza A show signs of coughing, high fever, difficulty breathing, runny nose, loss of appetite, 
and immobility (APHIS, 2013). Swine can be vaccinated for swine influenza and it is also highly 
advised that those who work with swine receive a seasonal vaccination to prevent influenza A 
virus transmission from swine to humans and vice versa (APHIS, 2013).  
Summary 
 Pork lungs are currently not allowed to be saved for human consumption based on the 
USDA-FSIS regulation, 9 CFR 310.16 (1971). Schwabe (1979) along with others have noted that 
lungs are widely consumed throughout the world. Unfortunately, there is a lack of research 
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indicating which, if any, pathogens or debris reside within the lungs. Microorganisms of interest 
to the pork industry include Campylobacter spp., Yersinia spp., non-O157:H7 STEC’s, 
Escherichia coli O157:H7, Streptococcus suis, Mycobacterium spp., Type A influenza viruses, 
Staphylococcus aureus, and Salmonella spp. (Baer et al., 2013). Results showing little to no 












Results from a brief email survey to U.S. Meat Export Federation Regional Directors 
indicated that domestic and imported porcine and bovine lungs were consumed by humans in 
Asia as well as South and Central America. European countries proved to be the exception. With 
the majority of international markets consuming porcine lungs, an enormous opportunity for 
exporting lungs into those markets could exist. However, USDA-FSIS regulations prohibit 
saving lungs from all livestock species for the purpose of human food. Specifically, for pork, 
production practices have changed drastically over the past 40 years. Many of these changes may 
improve the safety of porcine lungs as a human food.  
According to USDA-FSIS regulation, 9 CFR 310.16, livestock lungs shall not be saved for 
human food. This regulation became a final rule in June 17, 1971, and seemingly has not been 
disputed or investigated since. In a separate document for “proposed rule making” dated 
December 31, 1969, further explanation of the reasoning for not allowing lungs from livestock to 
be used for human consumption was explained briefly. It was specifically stated that several 
hundred beef lungs were evaluated by trained pathologists, who reported that 93.5% of lungs 
were affected with various abnormal conditions. This included lungs being adulterated with 
airborne or induced external substances such as dust, molds, rumen ingesta, nasal exudate, etc. It 
was determined that these contaminants were imbedded deeply in the smallest “air tubes” 
(alveoli) of the lungs and that it is not feasible to microscopically examine all parts of the lung 
before passing them for human consumption. As a result, in 1971, lungs from all livestock 
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species were no longer permissible for human consumption.  Other than the information 
provided in the aforementioned documents, there is minimal, if any, other explanation for 
deeming lungs inedible for humans. Interestingly, this is not a mandate in the Federal Meat 
Inspection Act, and this regulation can be amended or suspended via a formal petition to USDA-
FSIS, provided that ample evidence is provided supporting the amendment. Therefore, it was the 
objective of the proposed research to provide evidence of the safety of porcine lungs for human 
consumption via determining prevalence of potentially pathogenic bacteria and infectious agents 
known to be prevalent in pork. This included determining prevalence the seven predominant 
STEC’s, Salmonella spp., and Campylobacter spp. Additionally, discussions with USDA 
indicated that pneumonia, and particularly tuberculosis, may be of great concern to USDA-FSIS 
when considering allowing lungs for human consumption. According to the National Veterinary 
Services Laboratory (NVSL), who performs the surveillance of tuberculosis for USDA and the 
Department of Wildlife, M. bovis has the greatest potential to be discovered in porcine lungs due 
to comingling with cattle; however, detecting any of the Mycobacterium spp. in domesticated 
porcine lungs was unlikely due to modern production practices, specifically confinement 
production practices. Mycobacterium spp. are generally known to result from the soil and non-
potable water sources, and the vast majority of market hogs (young and old) are not exposed to 
either of these sources. The supervisor of bacteriology at NVSL, the individual in charge of 
USDA’s national surveillance for tuberculosis, indicated via personal communication that there 
is not an extremely high likelihood that Mycobacterium spp. associated with tuberculosis will be 
cultured from the lungs of domestic swine. Additionally, most all sources, including USDA, 
agreed that foodborne tuberculosis is not the primary transmission mechanism in the U.S. and 
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over 90% of healthy youth and adults are immune; however, exposure to animals infected with 
M.bovis and M. tuberculosis can cause paratuberculosis in humans.  
Materials and Methods 
Pork Lung Collection Process 
Lungs (N = 288) were collected in April and May of 2014 from a total of six federally 
inspected pork processing facilities; four commercial pork processing plants that were harvesting 
youthful, market weight gilts and barrows and two commercial pork processing plants that were 
harvesting mature sows. An equal number of lungs (n=48) was collected from each plant. It 
should be noted that the processing plants harvesting sows were not using a hot water scalding 
technique to dress the animals.  The sows that were harvested were skinned hot on the harvest 
floor immediately after being bled, whereas the young barrows and gilts were scalded.   
In an attempt to obtain a representative sample of the production facility on an average 
working day, animals and corresponding lungs were randomly selected throughout the entire 
production day. Pork lungs collected from each of these plants were federally inspected and only 
lungs that passed inspection were used in the study. In the event that an individual animal or any 
of its internal organs were condemned, the lungs were not collected from that animal. All of the 
lungs collected were removed and processed using aseptic techniques to prevent any exogenous 
contamination. Each lung was removed from the carcass using sterile gloves and then placed on 
a sheet of parchment paper that had been properly sterilized (autoclaved parchment paper 
individually and aseptically packaged).  In addition, the surface underneath the parchment paper 
was cleaned and sterilized with a 70% alcohol solution between each collection period.  A new 
pair of sterile gloves and parchment paper was used for each sample. Each sample collected for 
presence of pathogens was a composite sample consisting of five randomly selected lungs that 
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were consecutively pulled off the production line, except for the 48 samples collected for 
histopathological examination. The 48 samples collected for histopathological examination each 
represented one lung and were randomly selected one at a time every hour.  
Processing and Shipping the Pooled Samples for Pathogenic Testing 
Each pooled sample consisted of approximately 500 g of lung tissue from five animals. 
Tissue was removed from lungs using sterilized scissors and scalpels.  Each individual lung had 
approximately 100 g of total tissue removed from the apical lobes, middle lobe, diaphragmatic 
lobes, and the accessory lobe located on the right side of the lung. Unlike histology samples, 
there was no lymph node tissue included in pooled samples. All excisions were then placed into 
a single Whirl-Pak bag which was then placed directly into a refrigerated environment.  
Immediately following a day’s collection, samples were placed in a cooler containing ice packs 
and then shipped overnight to a commercial laboratory. Samples were adequately insulated with 
newspaper to prevent direct contact with the ice packs. Microbiological samples were screened 
by an accredited commercial laboratory (Food Safety Net Services, San Antonio TX) for the 
prevalence of Salmonella spp., Campylobacter spp., Staphylococcus aureus, STEC, Yersinia 
spp., mold, and yeast. Paired samples were also sent to the University of Minnesota Veterinary 
Diagnostic Lab to be tested for the prevalence of Streptococcus suis. Colorado State University 
Veterinary Diagnostic Laboratories tested for the prevalence of Mycobacterium spp. and 
Influenza. In each case, prior to prevalence screening, individual (pooled) samples were 
pummeled/homogenized in order to obtain a representative sample. 
Processing and Shipping the Histology Samples 
Each histology sample (n = 48) consisted of 5 segments from a single lung, which was 
randomly selected. For each lung designated for histology, samples were obtained in the 
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processing plant from the following five anatomical locations: 1) cross-section from the middle 
of the right apical lobe; 2) cross-section from the middle lobe; 3) tip of the accessory lobe; 4) 
cross-section from the right diaphragmatic lobe; and 5) tracheobronchial lymph node (Figure 
3.1). Samples were removed from the lung using sterilized scissors. Samples were then placed 
into a Whirl-Pak bag, and refrigerated. For shipping, the Whirl-Pak bags containing the histology 
samples were placed in a cooler containing cold packs and then shipped overnight to the 
Colorado State University Diagnostic Lab. Samples were adequately insulated with newspaper to 
prevent direct contact with the cold packs. Colorado State University conducted the 
histopathological examinations. Tissue were fixed by immersion in a 10% neutral buffered 
formalin and routinely processed. Five micron sections of each tissue were stained with 
hematoxylin and eosin for examination. 
Pathogen Testing Procedures 
Mycobacteria Procedure 
 Mycobacteria testing was conducted by Colorado State University Veterinary Diagnostic 
Lab (Fort Collins, CO) following procedures outlined by Fyock and Whitlock (1999; Appendix 
A). Lung tissue samples were reduced to 2 g and placed in a conical tube containing 35 ml of 
sterile water. Tube was mixed vigorously and then placed in a vortex for 30 minutes. Tube was 
left standing at room temperature for at least 30 min after being removed from the vortex. A total 
of 5 ml of the sample was removed from the top one third of the test tube and placed in a new 50 
ml conical tube containing 25 ml of room temperature BHI/HPC (0.75% HPC). The tubes were 
incubated at 35-37°C for 18-24 hrs. Samples were then centrifuged for 30 minutes at 900 x g. 
Supernatant was removed and the cellular debris pellet was suspended with 1 ml of the antibiotic 
brew. Tubes were incubated again at 35-37°C overnight. Four test tubes were inoculated at room 
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temperature with Herrold’s Egg Yolk agar (three with mycobactin and one without) with .250 µl 
of the resuspension. Samples plated on Herrold’s Egg Yolk agar were incubated at 37°C in a 
slanted position with loose caps. The caps were tightened after 1-2 weeks and moved to an 
upright position in the incubator. Colony counts were recorded every 2 weeks for 16 weeks 
(Russell, 2012).  
APC Procedure 
 Aerobic Plate Count testing was conducted by Food Safety Net Services (San Antonio, 
TX) following 3M’s procedure titled “Petrifilm Aerobic Plate Count” (β014; Appendix B). 
Petrifilm Aerobic Count plates from 3M were used to analyze aerobic bacteria counts. The 
samples were diluted with Butterfield’s Phosphate Buffer in a sterile bag. Samples were 
mechanically pummeled for 2 min. Appropriate dilutions were plated to enumerate aerobic plate 
counts. Petrifilms were incubated with the clear side up for 48 hrs ± 3 hrs at 35°C ± 1°C. APC 
counts were reported in CFU/g. 
Salmonella Procedure 
 Salmonella testing was conducted by FSNS (San Antonio, TX) following bioMėrieux’s 
procedure (VIDAS® Easy SLM; Appendix C). A 25 g sample of lung tissue was enriched with 
225 ml of broth and then pummeled for 2 min. Sample was then incubated for 16-22 hrs at 35°C 
± 1°C. Next, a 0.1 ml sample of the inoculum was added to the VIDAS strip and placed in the 
VIDAS Heat and Go to warm for 15 min. The VIDAS strips were removed and cooled at room 
temperature for 10 min. Results were recorded after 45 min.  
Yeast and Mold Procedure 
 Yeast and mold testing was conducted by FSNS (San Antonio, TX) following the 
procedures outlined in the Bacteriological Analytical Manual (BAM; Tournas et al., 2001; 
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Appendix D). Each lung tissue sample was divided into 50 g subsets and applied to plates with 
Dichloran rose bengal chloramphenicol (DRBC) agar. Samples were incubated in the dark at 
25°C for five days. Samples were incubated for an additional 48 hrs to allow time for heat or 
chemically-stressed cells and spores to grow if no growth was detected after the initial five days. 
Campylobacter Procedure 
 Campylobacter testing was conducted by FSNS (San Antonio, TX) following the 
DuPontTM BAX® System Real Time PCR Assay for Campylobacter (2013; Appendix E). A 25 g 
sample of lung tissue was diluted by a factor of 1:10 in single-strength Bolton broth. A total of 
200 µL of lysis reagent and 5 µL of the diluted sample were added to cluster tubes. The cluster 
tubes were then heated for 20 minutes at 37°C followed by 10 min at 95°C in a dry block heater. 
Cluster tubes were cooled for 5 min before 30 µL of their content was transferred to PCR tubes 
in a cooling block. PCR tubes were placed in a PCR cycler for 90 min to receive the final results. 
Streptococcus suis Procedure 
 Testing for Streptococcus suis was conducted by the University of Minnesota Veterinary 
Diagnostic Lab following their SOP titled “S. suis Detection PCR” (2014; Appendix F). 
Microbial DNA was extracted from pork lung tissue and used for a PCR test. The PCR master 
mix was prepared using Hot StarTaq mixture, JP4 F primer, JP5 R primer, and PCR water. A 2 
µl sample of DNA extracted from the sample was added to the master mix along with a 2 µl 
sample of template DNA. The PCR reaction tubes containing the sample DNA and PCR master 
mix were placed into a GeneAmp PCR System 9700 Thermalcycler and ran at the appropriate 
time and temperatures for the Streptococcus suis detection PCR program.  A 12 µl PCR product 
from each sample was added to a 1% TAE-agarose gel stained with ethidium bromide and used 
for Gel Electrophoresis. A gel image for each sample was collected and the detection of 
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Streptococcus suis was determined based on the presence of a band at approximately 688 base 
pairs.   
Yersinia spp. Procedure 
 Testing for Yersinia spp. was conducted by FSNS (San Antonio, TX) following the 
Yersinia spp. testing procedures outlined in the BAM (Feng and Weagant, 2001; Appendix G). A 
25 g sample was enriched with Peptone sorbitol bile broth (PSBB) and homogenized for 30 
seconds. Samples were then incubated at 10°C for 10 days. Enrichment broth was removed from 
the incubator on day 10 and thoroughly mixed. One loop of enrichment was transferred to 0.1 ml 
of 0.5% KOH in 0.5% saline and mixed for 2-3 sec. One loop of the new mixture was streaked 
on a MacConkey agar plate. An additional 0.1 ml of enrichment was added to 1 ml of 0.5% 
saline, mixed for 5-10 sec, and streaked on an additional MacConkey agar plate. Plates were 
incubated for 1-2 days at 30°C and examined for colonies. No suspected Yersinia spp. grew on 
the MacConkey agar so no additional confirmatory agars were needed. 
Staphylococcus aureus Procedure 
 Testing for Staphylococcus aureus was conducted by FSNS (San Antonio, TX) following 
the Staphylococcus aureus testing procedures outlined in the BAM (Bennett and Lancette, 2001; 
Appendix H). A 1 ml sample was distributed equally to 3 plates of Baird-Parker agar. Inoculum 
was spread over the surface of agar and placed inverted in an incubator for 45-48 hrs at 35°C. 
Plates were removed and colony counts were recorded. Samples that did not have any visual 
growth of Staphylococcus aureus were recorded as having < 10 CFU/g. 
Non-O157:H7 STEC Procedure 
 Testing for non-O157:H7 STEC was conducted by FSNS (San Antonio, TX) following 
the USDA-FSIS Microbiology Laboratory Guidebook 5B.05 (2014; Appendix I). A 325-375 g 
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sample was placed in a sterile bag with a mesh filter. A total of 975 g of Modified Tryptone Soya 
Broth (mTSB) was added to the sample and pummeled until well mixed. Samples were 
incubated at 42°C for 15-24 hrs. Samples were analyzed by a real-time PCR using the BAX® 
system. 
Type A Swine Influenza Virus Procedure 
 Testing for Type A Influenza was conducted by Colorado State University Veterinary 
Diagnostic Lab following the National Veterinary Services Laboratory’s SOP written by Koster 
(2012; Appendix J). Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) SOP 
for the National Veterinary Services Laboratories was used as a reference for the detection of 
Type A Swine Influenza Virus. A probe monitored the target PCR product formation at each 
cycle during the PCR reaction. Probes were labeled with a reporter dye at one end and a non-
fluorescing quencher at the other end. The amount of fluorescence that was generated and the 
cycle number of detection was proportional to the amount of target template. 
Results and Discussion 
The primary objective of this research was to determine whether or not pork lungs could 
in fact be saved for human consumption. Microbiological tests were conducted to determine 
prevalence of key pathogens of interest to the pork industry and we completed a 
histopathological examination of pork lungs to determine whether or not physical contamination 
resides within lung tissue. Current USDA-FSIS regulations prevent all livestock lungs from 
being saved for human consumption within the U.S. Unfortunately, this rule is currently 
preventing the pork industry from capturing a potential economic benefit if in fact pork lungs are 
safe to eat. However, results from this project demonstrated that prevalence of certain pathogens, 
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such as Salmonella and STEC, and contamination with foreign materials occur at high 
frequencies in pork lungs at slaughter (Table 3.1).  
Pathogen data 
 Samples collected for specific pathogen testing were pooled samples that each contained 
lung tissue from five hogs. A total of 49 samples that were retrieved from both the market 
barrows/gilts and the mature sows tested positive for Salmonella spp., Shiga toxin-producing 
Escherichia coli, Campylobacter, and Streptococcus suis. Salmonella and STEC were the most 
prevalent in the pooled lung samples. Salmonella was found in approximately 54.2% of all the 
samples collected and at least one STEC was found in approximately 31.3% of the samples 
(Table 3.1). All fifteen of the samples testing positive for STEC contained more than one Shiga 
toxin-producing E. coli and three of these samples actually contained all six of the major STEC 
(Table 3.2). One sample (2.3%), tested positive for Campylobacter (Table 3.1). Streptococcus 
suis was found in 21.9% of the samples from young market hogs but was not found in any of the 
samples collected from the sows (Table 3.1). Prevalence of Yersinia spp., Influenza, and 
Mycobacterium spp. were also tested for, however no samples tested positive for these 
pathogens. 
Histology data    
 Histopathology results indicated that 25 of the 48 samples from the 48 hogs contained 
aspirated material (Table 3.3). Aspirated material included either plant material, blood, or fluid 
that appeared to originate from oropharynx. Of the 25 lung tissue samples that showed evidence 
of aspirated material, 24 of these samples came from hogs that were sent through a hot water 
scalding process. The remaining sample that contained aspirated material was from a sow that 
was skinned and not scalded. Figure 3.2 shows that 52.1% of all the hogs sampled aspirated, 
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75% of the hogs that were hot scalded aspirated, and 6.3% of the hogs that were skinned and not 
hot scalded aspirated. Although aspiration appeared to be much more common in the hogs that 
were scalded, prevalence of major pathogens found in these hogs was less than pathogen 
prevalence in hogs that were skinned. Table 3.3 shows the pathogens prevalent in the lung tissue 
under the two different processing methods (skinning or hot scalding). 
APC, Staphylococcus aureus, Mold, and Yeast Data 
 In addition to the previously mentioned pathogens that were tested for, mold, yeast, 
Staphylococcus aureus, and aerobic plate counts were also taken from each composite sample. 
Mold counts for all the samples were not detectable (<10 CFU/g). Yeast counts for lungs from 
all sows were not detectable (<10 CFU/g), however, 20 of 24 samples from young market hogs 
had yeast counts >10 CFU/g. Staphylococcus aureus was not detectable (<10 CFU/g) in 47 of 48 
lung samples, however, it was detected (60 CFU/g) in one sample from a young market hog. 
Aerobic plate counts were high in lungs from both sows and market hogs. The average APC for 
the market hog lung samples was 23,838 CFU/g but only 3,115 CFU/g for the sows (Table 3.4). 
 


























1Shiga toxin producing Escherichia coli. 
2Market ready barrows and gilts. 
3Sows which have farrowed at least one litter.  



















Salmonella 32 16 50.0% 16 10 62.5% 48 26 54.2% 
Campylobacter 27 0 0.0% 16 1 6.3% 43 1 2.3% 
STEC1 32 10 31.3% 16 5 31.3% 48 15 31.3% 
Yersinia spp. 32 0 0.0% 16 0 0.0% 48 0 0.0% 
Strep. suis 32 7 21.9% 16 0 0.0% 48 7 14.6% 
Influenza 32 0 0.0% 16 0 0.0% 48 0 0.0% 







    1Shiga toxin producing Escherichia coli strains tested for include O26, O45, O103. O111, O121, and O145. 
 
  
Table 3.2. Frequency of individual STEC strains1 found in pork lungs (n = 48). 
 Number of STEC 
 1 2 3 4 5 6 
Barrow/gilt samples 0 2 1 1 3 3 
Sow samples 0 3 2 0 0 0 





Table 3.3. Pathogens prevalent in pork lungs using different processing techniques. 
Processing Technique Salmonella STEC Campylobacter 
Scalding 50.0% 31.3% 0.0% 




Figure 3.2. Frequency distribution of lungs containing aspirated material among the total hogs, 











Total % Aspirated % Aspirated (Hot Scalded) % Aspirated (Skinned)
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Table 3.4. Mold, yeast, Staphylococcus aureus, and aerobic plate counts (APC) in pooled pork 
lung samples. 
  Mold avg. Staph. aureus APC avg. Yeast avg.  
Barrow/Gilt Samples <10 CFU/g <10 CFU/g 23,838 CFU/g 255 CFU/g 
Sow Samples <10 CFU/g <10 CFU/g 3,115 CFU/g <10 CFU/g 












Binders have been used by the meat industry for many years to create innovative 
restructured products. Fibrin is an example of one particular cold set binding product that can be 
used on fresh meat. Fibrin is produced by combining two components extracted from blood. The 
first component is fibrinogen, the primary binding protein, and the other component is thrombin, 
an enzyme that catalyzes cross-linking of collagen helices leading to the binding process (Ryan 
et al., 1999; Barrett et al., 2004; Toldra et al., 2012). Fibrin naturally occurs when the protein 
fibrinogen is activated by the enzyme thrombin, thereby forming a strong bond of muscle tissue. 
Fibrin is effectively used in the meat and food industries to create value-added muscle foods. 
Fibrin is currently sold commercially in the U.S. as Fibrimex® by Sonac, a European company 
owned by Darling International. The patent held by Sonac for manufacturing fibrin from blood 
has expired (Paardekooper and Wijngaards, 1986); therefore, it is reasonable to believe that U.S. 
pork operations could begin to collect blood at the time of slaughter and isolate fibrinogen and 
thrombin from blood in house to create fibrin. Ultimately, fibrin has potential as a binding agent 
to create novel items for export markets using variety meats and offal items. 
Materials and Methods 
A total of eight products were developed using pork variety/offal meats and beef fibrin 
purchased from Sonac. Beef fibrin was the only fibrin available from Sonac at the time of this 
project. The commonly exported items that were used are listed in Table 4.1. Fibrin obtained 
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from Sonac was sold frozen in two separate containers; one containing fibrinogen and the other 
containing thrombin. The fibrinogen and thrombin remained frozen before use.  
 Fibrinogen and thrombin containers were submerged in 26.6°C water until they reached 
liquid form. Initial temperature of the water must be 26.6°C in order to maintain the binding 
factors of the two components. Fibrinogen and thrombin were mixed together at a ratio of 10:1 to 
create the fibrin. Binding began when fibrin was added to the protein source. Products were 
developed using fibrinogen at 10% and thrombin at 1% of the total weight of the meat block. 
Ground products developed had a larger surface area and required a greater amount of fibrin.  
Product Development 
Diaphragm Steak-like Product 
A steak-like product was made using pork diaphragms and beef fibrin. A sensory test was 
conducted before the product was developed to assure the most ideal processing and cookery 
methods were used. The side of the diaphragm that touched the ribcage contained a thick piece 
of connective tissue that was not removed by the plant. Connective tissue was removed to 
improve tenderness and to better imitate the composition of a steak. Grilling was determined to 
be the most ideal method of cooking. 
Raw product was made after determining the ideal processing and cooking methods. A 15 
cm x 30 cm x 6 cm pan was used as the mold to form a loaf with the diaphragm. A total of 2.26 
kg of diaphragm meat with the connective tissue removed, 226 g (10%) of fibrinogen, and 23 g 
(1%) of thrombin were thoroughly mixed by hand for one minute. Pieces of diaphragm were 
layered in the pan quickly before the fibrinogen and thrombin began setting. Plastic wrap was 
placed over the top layer and a pre-cut cardboard cap was placed on the top of the plastic wrap. 
The pan was then placed in a vacuum sealable bag and a vacuum was drawn. Vacuum helped 
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eliminate air pockets between the pieces of meat which ultimately maximizes binding area. The 
vacuum sealed product was then placed in the cooler at 2°C for 12 hours to allow the binding 
process to complete. 
Final product was removed from the bag and pan after12 hrs of required setting time and 
sliced into 2.54 cm steaks and then grilled. After cooking, steaks maintained structural integrity 
and fibrin held meat together effectively resulting in no holes or weak binding points within 
steaks. Refer to figure 4.1 for pictures of the raw and cooked final product. 
Boneless Baby-Back Rib-like Product (Jowl) 
A boneless baby-back rib-like product was developed using jowl trimmings from pork 
carcasses. Jowls that are processed in plants are skinless and appear to have a very minimal 
amount of fat trimmed off; therefore, jowls used to make boneless baby-back rib-like products 
had approximately 20% of their fat removed before being added to the final product in order to 
increase the lean point. Each individual piece was placed in an electric meat tenderizer. A total of 
13.6 kg of tenderized jowl trimmings, 1.36 kg (10%) of fibrinogen, and 136 g (1%) of thrombin 
were thoroughly mixed for about one minute. Pieces were layered in a 50 cm x 30 cm x 6 cm 
loaf pan. Plastic wrap was placed over the top layer and a pre-cut cardboard cap was placed over 
the top of the plastic wrap. Final product was placed in a vacuum sealable bag and a vacuum was 
drawn. Product was placed in the cooler at 2°C for at 12 hrs to allow the binding process to 
complete.  
 Product was placed in the freezer at -20°C after initial 12 hrs in the cooler. The binding 
process must be complete before a product is frozen or weak points between the pieces of meat 
developed. The frozen boneless baby back loaf was then tempered until the internal and external 
temperatures fell within the range of -4.4°C to -2.2°C. This temperature range reduced the chance 
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of tearing the meat with the knife. The loaf was cut into 2.54 cm thick pieces using a custom 
edged knife with a zig-zag design which cut the meat to imitate the look of a traditional bone-in 
baby back rib. The final product was best when grilled. Refer to figure 4.2 for pictures of the raw 
and cooked final product. 
Bung Roll (Liver, Kidney, Heart) 
The bung roll was developed to test the binding capability of fibrin on offal meats that 
contained a high percentage of water. Whole livers, hearts, and kidneys were selected from pork 
carcasses and then coarse ground together at a ratio of 1:1:1. Flushed pork bungs were tied off at 
one end, soaked in saltwater, and used as the casing for the ground livers, hearts, and kidneys. 
Ground offals were weighed and fibrinogen was added at 12% of the weight of the meat block 
and thrombin was added at 1.2%. The mixture was thoroughly tumbled by hand for 
approximately one minute before being placed in the cylinder of a hand stuffer. A bung was 
placed over the stuffing tube and filled to a level where the bung could be tied off at the open 
end. The bung roll was placed in a vacuum sealable bag and a vacuum was drawn. Product was 
then placed in the cooler at 2°C for 12 hours to allow the binding process to complete.  
 The bung roll was removed from the cooler after the required 12 hrs of chilling. The roll 
was further processed in three different ways. The first attempt involved slicing the chilled bung 
roll that had an internal temperature of 2.2° C. Slicing did not work because it appeared as 
though there was too much purge to allow the fibrin to set appropriately. For the second 
processing method the bung roll was frozen at -20°C, tempered to -3.3°C, and then sliced at 0.6 
cm. Slices held together and remained one solid piece after frying for approximately 10 min. The 
most ideal processing method was to cook the bung roll in an oven set to 149°C and 100% 
humidity until an internal temperature of 82°C was reached. Offal meat within this bung roll 
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remained intact when sliced with a knife. Refer to figure 4.3 for pictures of the raw and cooked 
final product. 
Heart and Fat Steak 
The heart and fat steak was developed to determine fibrin effectiveness with a low 
moisture ground product. Pork back fat and hearts that had large visible veins removed were 
coarse ground once and then mixed together by hand for 3 min. A total of 907 g of heart and 340 
g of fat were used to fill a 15 cm x 30 cm x 6 cm loaf pan. Fibrinogen and thrombin were added 
at a rate of 12% and 1.2% respectively to the ground product and then mixed again thoroughly 
by hand for approximately 1 min. Plastic wrap was placed over the top layer and a pre-cut 
cardboard cap was placed on the top of the plastic wrap. Final product was then placed in a 
vacuum sealable bag and a vacuum was drawn. Product was then placed in the cooler at 2°C for 
12 hrs to allow the binding process to complete. 
 Final product was removed from the cooler after 12 hrs and then removed from the bag 
and pan. The loaf was sliced into 2.54 cm thick steaks and the steaks were grilled. Steaks 
remained intact and had very few weak points between the meat and fat particles. Refer to figure 
4.4 for pictures of the raw and cooked final product. 
Boneless Hock 
 The boneless hock is an example of how a cut that is typically sold with the bone intact 
can be deboned and bound together to form one solid piece that consumers may find more 
acceptable. The boneless hock was perhaps the most practical product developed since it 
ultimately represents products such as bone-in hams which could potentially lead to 
opportunities in both foreign and domestic markets. Pork packers that sell the hocks market them 
as bone-in. To make the boneless hock, the bone was removed from the meat portion of the hock 
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and a mixture of 10% fibrinogen and 1% thrombin was rubbed into the center portion of the 
hock. The hock was then folded back into its original shape, placed in a vacuum package bag, 
and finally sealed. Final product was left in the cooler at 2°C for 12 hrs. Refer to figure 4.5 for 
pictures of the final product. 
Sliced Tongue 
 A log containing skinned pork tongues was developed to show binding capabilities of 
whole muscles within a synthetic casing. Sliced beef tongue is a popular Asian dish and the 
result of binding pork tongues together is a larger diameter product that is more similar in size to 
a beef tongue.  A total of 2.7 kg of skinned pork tongues were combined with a mixture 
containing 10% fibrinogen and 1% thrombin. Tongues and fibrin were tumbled by hand for 
approximately 1 min before being layered into an Aligned Grain Stuffer (AGS). A 7.6 cm 
diameter perforated synthetic casing that was tied off at one end was placed over the mouth of 
the AGS. The perforated casing helps remove air pockets that may result and prevents the need 
for vacuum sealing. The air powered AGS was turned on and stuffed the aligned tongues into the 
casing. The casing was tied off and the final product was left to chill for 12 hours in the cooler at 
2°C. 
 The tongue log was removed after the appropriate chilling period and the casing was 
removed. The log was cut into 0.3 cm slices using a deli meat slicer and 0.6 cm slices using a 
knife. Slices were then cooked in a frying pan to 74°C. The slices remained intact and did not 







The diaphragm pinwheel is a novelty item that shows fibrin will bind meat, even when 
other ingredients are incorporated. First, skinned diaphragms and a slurry containing 10% 
fibrinogen and 1% thrombin were hand-mixed together for approximately one minute. Two 
pieces of diaphragm were used to create each pinwheel. The two pieces were lined up and 
overlapped each other by 5 cm. Outside ingredients added to the pinwheels include cheese, 
orange bell pepper slices, and cilantro. These three ingredients were added to one side of the 
diaphragm strips and gaps between the ingredients were left in order to allow for the protein to 
protein contact that is necessary for binding. Continuous diaphragm strip was then rolled up on 
itself to keep the added ingredients inside the pinwheel. The pinwheel was placed in a round 
plastic form, vacuum sealed in a bag, and then placed in the cooler at 2°C for 12 hrs to allow the 
binding process to complete.  
 The pinwheel was removed from the bag and the plastic form after the appropriate 
chilling period. The pinwheel was grilled to test the fibrin’s ability to continue to hold together 
both the meat and the added ingredients. Product remained intact and maintained its original 
structure through the cooking process. Refer to figure 4.7 for pictures of the raw and cooked final 
product. 
Jowl Bacon 
 The jowl bacon is a product derived from the same form as the boneless baby back. 
Although the bacon procured for this product is fresh and uncured, similar cured products such 
as hams have been procured using fibrin making a cured bacon-like product a possibility 
(Romero de Avila et al., 2014). The same procedures were used to make the bacon; however, the 
frozen jowl loaf was sliced using a vertical band saw at 0.3 cm. The same jowl loaf can be 
44 
 
thawed and sliced using a meat slicer as an alternative. Refer to figure 4.8 for pictures of the raw 
and cooked final product. 
Results and Discussion 
 
The purpose of this research was to determine whether or not fibrin could serve as an 
effective binder for pork variety and offal meats. Prior to this research, no work had been 
completed using fibrin with pork variety and offal meats. Fibrin was added to a wide array of 
different variety and offal meats to determine its efficacy on products containing different levels 
of water and collagen. Application directions and production advice from Boles and Shand 
(1999), Lennon et al. (2010), and Paardekooper and Wijngaards (1986) were utilized to define 
the process when making the final products. 
As expected, pork fibrin served as an effective binder in development of all final pork 
products. Paardekooper and Wijngaards (1986) proved fibrin effectively binds whole muscles 
together such as pork shoulder muscles and rolled beef, which is similar in concept to the 
boneless hock, diaphragm steak, tongue log, and diaphragm pinwheels. Boles and Shand (1999) 
used fibrin to create restructured steakettes from course ground inside rounds, chuck tenders, 
chuck clods, and tri-tip which mimicked some of the products developed over the course of this 
project such as the bung roll and the heart and fat steak. In the end, a total of eight unique 
products were successfully developed using fibrin and the pork variety/offal meats listed in 
Table 4.1. Figures 4.1 - 4.8 show both the raw and cooked form of the products. 
Products that were developed are prime examples of potential export items that could be 
made in plants across the U.S. The stipulations for this project required the use of commonly 
exported items which is why we chose to use only pork variety and offal meats. However, 
research has shown that fibrin can be successfully used to combine more traditional products 
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such as skeletal muscles. Limitations to fibrin seem to be relatively unknown and further 
research determining optimum inclusion levels, sensory evaluations on different product types, 
and the efficacy fibrin has with cured products could benefit the industry in the future. Potential 
products that utilize fibrin’s binding capabilities can range anywhere from a low-sodium 
boneless deli ham to a formed imitation bacon product made from pork jowls. Results from this 
study suggest that fibrin is a feasible naturally-occurring binder that could be utilized by the U.S. 








Table 4.1. List of products utilized as common pork export items. 
 
Jowls Hocks Skins 
Kidneys Tongues Livers 
Diaphragm (skirt) meat Jowls Fat-Back 
Hearts Rectum  
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I. If samples cannot be processed immediately, place them in a -70oC freezer or 
refrigerator for a maximum of 3 days.  
II. If you have a fecal sample weigh out approximately 2 grams (walnut size) and place 
the sample into a 50 ml conical tube containing 35 ml of sterile water. 
III. If you have a tissue sample mince up approximately 2 grams and place the sample 
into a 50 ml conical tube containing 35 ml of sterile water. 
IV. Shake the conical tube vigorously and vortex for 30 minutes to allow the sample to 
break up.  
V. After mixing, allow the tube to stand at room temperature for 30 minutes allowing the 
sample to settle to the bottom. 
VI. Transfer 5 ml of the sample from the upper third of the tube to a second 50 ml conical 
tube containing 25 ml of room temperature BHI/HPC (0.75% HPC). You can discard 
the water tube at this point but if so desired you may save the tube under the hood in 
room E117 for further use. 
VII.  Incubate BHI/HPC tubes at 35-37oC overnight. 
VIII. After 18-24 hours centrifuge the tubes for 30 minutes at 900 x g. 
IX. Pour off the supernatant and resuspend the pellet with 1 ml of the antibiotic brew and 
vortex well. 
X. Incubate at 35-37oC overnight (although the sample will be stable for up to 3 days) 
XI. Inoculate four tubes of room temperature Herrold’s Egg Yolk agar (γ with 
mycobactin and 1 without) with .250µl of the resuspension. Make sure you are using 
a different sterile pipette for each animal to avoid contamination. Roll the tubes so 
that the entire surface is covered with the inoculum.  
XII. Incubate Herrold’s Egg Yolk agar at γ7oC in a slanted position with caps loose.  
XIII. After the tube has been incubated for 1-2 weeks tighten the cap and place in the 
upright position in the incubator. 
XIV. Every 2 weeks for 16 weeks read and evaluate tube for growth/contamination. Record 
colony counts and describe contamination.  
XV. Slightly raised white-yellow colonies appearing at 6-12 weeks should be examined 






The Petrifilm Aerobic Count (AC) plate is a ready-made culture medium system that 
contains Standard Methods nutrients, a cold-water-soluble gelling agent, and an indicator that 
facilitates colony enumeration. Petrifilm AC plates are used for the enumeration of aerobic 
bacteria. 
3M Petrifilm™ Aerobic Count Plates Reminders for Use: Petrifilm Storage Sample 
Preparation Inoculation. Release top film; allow it to drop. Do not roll top film down. For 
detailed CAUTIONS, DISCLAIMER OF WARRANTIES / LIMITED REMEDY, 
LIMITATION OF 3M LIABILITY, STORAGE AND DISPOSAL information, and 
INSTRUCTIONS FOR USE see Product’s package insert. Add appropriate quantity of one of 
the following sterile diluents: Butterfield's phosphate buffer (IDF phosphate buffer, 0.0425 g/L 
of KH2PO4 adjusted to pH 7.2), 0.1% peptone water, peptone salt diluent (ISO method 6887), 
buffered peptone water (ISO method 6579), saline solution (0.85 - 0.90%), bisulfatefree letheen 
broth, or distilled water. Do not use buffers containing citrate, bisulfite, or thiosulfate; they can 
inhibit growth. Adjust pH of the diluted sample between 6.6 and 7.2.  For acid products, use 1N 










Yeast and Mold Procedures 
Enumeration of Yeasts and Molds in Food--Dilution Plating Technique 
A. Equipment and materials 
 
1. Basic equipment (and appropriate techniques) for preparation of sample homogenate, 
see Chapter 1 
2. Equipment for plating samples, see Chapter 3 
3. Incubator, 25°C 
4. Arnold steam chest 
5. pH meter 
6. Water bath, 45 ± 1° C 
  
B. Media and reagents 
 Media 
1. Dichloran rose bengal chloramphenicol (DRBC) agar (M183) 
2. Dichloran 18% glycerol (DG18) agar (M184) 
3. Plate count agar (PCA), standard methods (M124); add 100 mg chloramphenicol/liter 
when this medium is used for yeast and mold enumeration. This medium is not 
efficient when "spreader" molds are present. 
4. Malt agar (MA)(M185) 
5. Malt extract agar (Yeasts and Molds) (MEAYM)(M182) 
6. Potato dextrose agar (PDA), dehydrated; commercially available (M127) 
 Antibiotic solutions 
Antibiotics are added to mycological media to inhibit bacterial growth. Chloramphenicol is 
the antibiotic of choice, because it is stable under autoclave conditions. Therefore, media 
preparation is easier and faster due to the elimination of the filtration step. The 
recommended concentration of this antibiotic is 100 mg/liter medium. If bacterial 
overgrowth is apparent, prepare media by adding 50 mg/liter chloramphenicol before 
autoclaving and 50 mg/liter filter-sterilized chlortetracycline when the media have been 
tempered, right before pouring plates. 
Prepare stock solution by dissolving 0.1 g chloramphenicol in 40 ml distilled water; add this 
solution to 960 ml medium mixture before autoclaving. When both chloramphenicol and 
chlortetracycline are used, add 20 ml of the above chloramphenicol stock solution to 970 ml 
medium before autoclaving. Then, prepare chlortetracycline stock solution by dissolving 0.5 
g antibiotic in 100 ml distilled water and filter sterilize. Use 10 ml of this solution for each 
990 ml of autoclaved and tempered medium. Refrigerate in the dark and re-use remaining 
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stock solutions for up to a month. Stock solutions should be brought to room temperature 
before adding to tempered medium. 
C. Procedures 
 Sample preparation 
Analyze 25-50 g from each subsample; generally, larger sample sizes increase 
reproducibility and lower variance compared with small samples. Test individual 
subsamples or composite according to respective Compliance Program for the food under 
analysis. Add appropriate amount of 0.1% peptone water to the weighed sample to achieve 
10-1 dilution, then homogenize in a stomacher for 2 min. Alternatively, blending for 30-60 
sec can be used but is less effective. Make appropriate 1:10 (1+9) dilutions in 0.1% peptone 
water. Dilutions of 10-6 should suffice. 
 Plating and incubation of sample 
Spread-plate method. Aseptically pipet 0.1 ml of each dilution on pre- poured, solidified 
DRBC agar plates and spread inoculum with a sterile, bent glass rod. DG18 is preferred 
when the water activity of the analyzed sample is less than 0.95. Plate each dilution in 
triplicate. 
Pour-plate method. Use sterile cotton-plugged pipet to place 1.0 ml portions of sample 
dilution into prelabeled 15 x 100 mm Petri plates (plastic or glass), and immediately add 20-
25 ml tempered DG18 agar. Mix contents by gently swirling plates clockwise, then 
counterclockwise, taking care to avoid spillage on dish lid. After adding sample dilution, 
add agar within 1-2 min; otherwise, dilution may begin to adhere to dish bottom (especially 
if sample is high in starch content and dishes are plastic) and may not mix uniformly. Plate 
each dilution in triplicate. 
From preparation of first sample dilution to pouring or surface-plating of final plate, no 
more than 20 min (preferably 10 min) should elapse.  Note: Spread plating of diluted 
sample is considered better than the pour plate method. When the pour plate technique is 
used, fungal colonies on the surface grow faster and often obscure those underneath the 
surface, resulting in less accurate enumeration. Surface plating gives a more uniform growth 
and makes colony isolation easier. DRBC agar should be used for spread plates only. 
Incubate plates in the dark at 25°C. Do not stack plates higher than 3 and do not 
invert. Note: Let plates remain undisturbed until counting. 
 Counting of plates 
Count plates after 5 days of incubation. If there is no growth at 5 days, re-incubate for 
another 48 h. Do not count colonies before the end of the incubation period because 
handling of plates could result in secondary growth from dislodged spores, making final 
counts invalid. Count plates containing 10-150 colonies. If mainly yeasts are present, plates 
with 150 colonies are usually countable. However, if substantial amounts of mold are 
present, depending on the type of mold, the upper countable limit may have to be lowered at 
the discretion of the analyst. Report results in colony forming units (CFU)/g or CFU/ml 
based on average count of triplicate set. Round off counts to two significant figures. If third 
digit is 6 or above, round off to digit above (e.g., 456 = 460); if 4 or below, round off to 
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digit below (e.g., 454 = 450). If third digit is 5, round off to digit below if first 2 digits are 
an even number (e.g., 445 = 440); round off to digit above if first 2 digits are an odd number 
(e.g., 455 = 460). When plates from all dilutions have no colonies, report mold and yeast 
counts (MYC) as less than 1 times the lowest dilution used. Isolate individual colonies on 





Campylobacter spp. Procedure 
BAX® System Protocol 
1. Create rack file and warm up cycler.  
 
2. Mix protease with lysis buffer and transfer 200 µL of lysis reagent to cluster tubes.  
3. Transfer 5-µL samples to cluster tubes.  
4. Heat cluster tubes for 20 minutes at 37°C, then 10 minutes at 95°C.  
5. Cool cluster tubes for 5 minutes in cooling block, then transfer 30 uL to PCR tubes in 
cooling block.  
6.  Place sealed PCR tubes in cycler and run program.  





Streptococcus suis Procedure 
UNIVERSITY OF MINNESOTA VETERINARY DIAGNOSTIC LABORATORY Standard 
Operating Procedure (SOP) Doc. No.: MB.SOP.0040 Revision: 4 Category: Molecular 
Bacteriology Section, Test Method Active Date: 04/04/2013 Title: S. suis Detection PCR Page 1 
of 5 SYS.FORM.016, REV03, 06/03/2009  
1. Purpose: To outline the protocol for a PCR test to detect Streptococcus suis in clinical tissues 
and bacterial isolates using Qiagen Hot StarTaq Master Mix kit.  
2. Responsibility: It is the responsibility of the VDL Section Head to ensure training for staff that 
will perform this SOP. It is the responsibility of laboratory personnel using this procedure to 
read, understand, receive training for, and agree to follow the procedure described in this SOP. 
 3. Definitions: PCR: Polymerase Chain Reaction  
4. Equipment and Material: 0.2 ml MicroAmp PCR Reaction tubes PCR reaction tube holder 
Pipettes Pipette tips 0.65 ml microfuge tubes GeneAmp PCR System 9700 Thermalcycler or 
equivalent Vortex Hot StarTaq Master Mix Kit (Qiagen, Cat # 203443, or equivalent) RNase, 
DNase- free PCR water Primers JP4: 5’ – GCA GCG TAT TCT GTC AAA CG – γ’ JP5: 5’ – 
CCA TGG ACA GAT AAA GAT GG – γ’ Sample DNA Positive (+) control: S. suis (reference 
strain) Organism Accession # Streptococcus suis S. suis Serotype 1 1% Agarose Gel with 14 or 
16 well combs (Protocol MB.SOP.0001). 1 X TAE Buffer 0.625 mg/ml Ethidium Bromide 
Solution 5X Loading Dye Hi-Low DNA Marker 
5. Safety: 5.1 Training for this procedure includes review of hazards and accident prevention, 
personal protective equipment (PPE) and other safety requirements based on a risk assessment of 
the specific methods, reagents, and/or equipment used. Specific requirements may be found in 
the body of the document. 5.1.1 Personal Protective Equipment (PPE) includes: 5.1.1.1 
Laboratory coat 5.1.1.2 Non-Latex, powder free gloves 5.2 University of Minnesota safety 
information and safety policies are available from the U of M Department of Environmental 
Health and Safety (DEHS) on their website (www.dehs.umn.edu). 5.3 Material Safety Data 
Sheets (MSDS) are available in a labeled binder in VDL Molecular Bacteriology Room 340. 
5.3.1 Hazardous chemicals used in this Procedure include: 5.3.1.1 Agarose (irritant to 
eyes/skin/respiratory tract) 5.3.1.2 Ethidium bromide solution (irritant to skin/eyes/respiratory 
system, toxic to ingest, potent mutagen) 5.3.1.3 TAE Buffer 50X (irritant to skin/eyes/respiratory 
tract) 5.3.1.4 Loading Dye (irritant to skin, eyes and respiratory tract, may affect kidneys) 5.4 All 
biological, chemical, and radioactive waste is disposed according to state, federal, and U of M 
requirements as found at www.dehs.umn.edu “Hazardous Waste”.  
6. Training: Laboratory personnel will receive training and will follow appropriate document 
review schedule. Training status is maintained within the sections and the SOP revision records 
are archived in the VDL Q-Pulse Document module.  
7. Procedure: 7.1 Please refer to MB.SOP.0065 Cleaning Procedures, and/or MOL.SOP.306 
Contamination Prevention for the proper method of sample/reagent handling and proper 
directional flow. 7.2 Obtain extracted DNA to be run (see SOP protocol MB.SOP.00013, 
Microbial DNA Extraction from Tissue or MB.SOP.0032 Microbial DNA Extraction from Gram 
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Positive Pure Cultures). 7.3 Record lot numbers and pipette numbers on the S. suis PCR Test 
Sheet (see MB.FORM.0018). 7.4 Record PCR tube number, along with the DNA extraction 
number, the VDL accession number, and any notes on the S. suis PCR Test Sheet. 7.5 Prepare 
primer stock if necessary (see protocol MB.SOP.0028 Standard Primer Dilution). 7.6 Calculate 
the volumes of master mix components and record in the table: Master Mix, using the following 
guidelines: Component Working Concentration Volume per 25 µl Reaction (µl) Final 
Concentration Hot StarTaq mixture * Note 1 12 *Note 1 JP4 F primer 10 µM 0.8 0.32 µM /µl 
JP5 R primer 10 µM 0.8 0.32 µM /µl PCR Water N/A 9.4 N/A Final Volume N/A 23 N/A DNA 
N/A 2 *Note 2 N/A *Note 1: For HotStarTaq components and concentrations see: Hot StarTaq 
PCR Handbook (October 2005) *Note 2: Add 2 µl of extracted DNA, no need to quantify. 7.7 
Prepare PCR master mix by vortexing each constituent and pipetting calculated volume into 
microfuge tube. 7.8 Vortex mixture well. 7.9 Clearly label 0.2 ml PCR reaction tubes with the 
PCR tube number and place them in a PCR reaction tube holder and tray. 7.10 Aliquot 23 µl of 
prepared master mix into each PCR tube. 7.11 Add 2 µl of sample template DNA into the 
respective PCR tube and mix well. Make sure to add the S. suis positive control, as well as a 
negative control, for each PCR run. 7.12 Remove the PCR reaction tubes and holder from the 
tray and place into the GeneAmp PCR System 9700 Thermalcycler. 7.13 Run program: s. suis 
detection pcr under username: simone: using reaction volume of 25 µl. (See MB.SOP.0006 
Operation instructions for the GeneAmp PCR 9700 Thermalcycler). S. suis Detection PCR 
Program: 1 st Hold: 35 cycles of: 2nd Hold: 95 C for 15 min 94 C for 30sec 72 C for 10 min 55 
C for 1 min 72 C for 2 min 7.14 Run Gel Electrophoresis for detection PCR: Use 12 l PCR 
product from each sample for electrophoresis in a 1% TAE-agarose gel stained with ethidium 
bromide. 7.14.1 Prepare a 1% gel as outlined in MB.SOP.0001 (Agarose Gel Prep with Ethidium 
Bromide Solution) depending on size requirements and the number of samples. 7.14.2 Record 
the lane number, and the well number, with the respective PCR tube number, the DNA extraction 
tube number and the VDL accession number in the Gel ID Map table (MB.FORM.0003). 7.14.3 
When the gel has solidified and casting ends have been removed, place gel in gel box with 
enough fresh 1 X TAE buffer to cover the wells. 7.14.4 Mix 2 µl loading dye into each PCR 
tube. 7.14.5 Remove the gel comb(s) 7.14.6 Add 10 µl High-Low DNA Marker into the first well 
of each lane used. 7.14.7 Mix PCR product and dye by pipetting up and down 3 times, and add 
12 µl into each respective well following the gel ID map table. 7.14.8 Put cover on gel box and 
turn on power supply. 7.14.9 Run gel until leading dye reaches at least 2.0 cm (around 30 
minutes). 7.15 Capture gel image digitally and on film (MB.SOP.0005, Gel Image Capturing) 
8. Acceptance Criteria: 8.1 Any abnormalities or departures from normal or specified conditions 
as described in this test method shall be recorded. 8.2 If a positive control for a PCR test yields a 
negative result, then the PCR test must be repeated. Likewise, if a negative control yields a 
positive result, then the PCR test must be repeated. 8.3 If a positive control begins to deteriorate 
(produces weak band) due to degradation of DNA, then a new positive control will be will be 
extracted, tested and used for PCR reaction.  
9. Interpretation of Results: 9.1 A sample is considered positive based on the presence of a band 
at approximately 688 base pairs. A sample is considered negative based on the absence of a band 






Yersenia spp. Procedure 
A.  
Equipment and materials 
1. Incubators, maintained at 10 ± 1°C, ± 35-37°C 
2. Blender, Waring or equivalent, 8000 rpm, with 500 ml-1 liter jar 
3. Sterile petri dishes, 15 x 100 mm 
4. Microscope, light 900X and illuminator 
5. Disposable borosilicate tubes, 10 x 75mm; 13 x 100mm. 
6. Wire racks to acommodate 13x100mm tubes. 
7. Vortex mixer. 
B. Media 
1. Peptone sorbitol bile broth (PSBB) (M120) 
2. MacConkey agar (M91) (use mixed bile salts; BBL Mac agar and DIFCO Mac CS are 
acceptable) 
3. Celfsulodin-irgasan-novobiocin (CIN) agar (M35) 
4. Bromcresol purple broth (M26) supplemented individually with the following 
carbohydrates, each at 0.5%: mannitol, sorbitol, cellobiose, adonitol, inositol, sucrose, 
rhamnose, raffinose, melibiose, salicin, xylose, and trehalose 
5. Christensen's urea agar (M40) (plated media or slants) 
6. Phenylalanine deaminase agar (M123) (plated media or slants) 
7. Motility test medium (M103). Add 5 ml of 1% 2,3,5-triphenyl tetrazolium chloride per 
liter before autoclaving. 
8. Tryptone broth, 1% (M164) 
9. MR-VP broth (M104) 
10. Simmons citrate agar (M138) 
11. Veal infusion broth (M173) 
12. Bile esculin agar (M18) 
13. Anaerobic egg yolk agar (M12) 
14. API 20E or Vitek GNI 
15. Trypticase (tryptic) soy agar with yeast extract (TSAYE) (M153) 
16. Lysine arginine iron agar (LAIA) (M86) 
17. Decarboxylase basal medium (Falkow) (M44) supplemented with 0.5% ornithine 
18. Congo Red-brain heart infusion agarose (CRBHO) (M41) 
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19. Pyrazinamidase agar slants (M131) 
20. PMP broth (M125) 
21. -D-glucosidase test (see instructions at end of chapter) 
C. Reagents 
1. Gram stain reagents (R32) 
2. Voges-Proskauer (VP) test reagents (R89) 
3. Ferric chloride, 10% in distilled water (R25) 
4. Oxidase test reagent (R54) 
5. Saline, 0.5% (sterile) (R66) 
6. Kovacs' reagent (R38) 
7. 0.5% Potassium hydroxide in 0.5% NaCl, freshly prepared 
8. Mineral oil, heavy grade, sterile (R46) 
9. API 20E system or Vitek system with GNI cards (bioMerieux) 
10. 1% Ferrous ammonium sulfate 
D. Enrichment 
The following simplified procedure for isolating Yersinia from food, water, and 
environmental samples is recommended. 
1. Analyze samples promptly after receipt, or refrigerate at 4°C. (Freezing of samples 
before analysis is not recommended, although Yersinia have been recovered from 
frozen products.) Aseptically weigh 25 g sample into 225 ml PSBB. Homogenize 30 s 
and incubate at 10°C for 10 days. 
2. If high levels of Yersinia are suspected in product, spread-plate 0.1 ml on MacConkey 
agar (15,55) and 0.1 ml on CIN agar (47,54) before incubating broth. Also transfer 1 
ml homogenate to 9 ml 0.5% KOH in 0.5% saline (4), mix for 2-3 seconds, and spread-
plate 0.1 ml on MacConkey and CIN agars. Incubate agar plates at 30°C for 1-2 days. 
3. On day 10, remove enrichment broth from incubator and mix well. Transfer one loop-
full of enrichment to 0.1 ml 0.5% KOH in 0.5% saline and mix for 2-3 s (4). 
Successively streak one loopful to MacConkey plate and one loopful to CIN plate. 
Transfer additional 0.1 ml enrichment to 1 ml 0.5% saline and mix 5-10 s before 
streaking, as above. Incubate agar plates at 30°C for 1-2 days. 
E. Isolation of Yersinia 
Examine MacConkey agar plates after 1 to 2 days incubation. Reject red or mucoid 




Y. enterocolitica on MacConkey agar 
o Lactose negative colonies 
o flat, colorless, or pale pink 
o 1-2 mm diameter 
 
Examine CIN plates after 1 day incubation. Select small (1-2 mm diameter) colonies having 
deep red center with sharp border surrounded by clear colorless zone with entire edge. 
Y. enterocolitica colonies on YSA (CIN) agar 
o deep red center 
o Surrounded by clear, colorless zone 
o 1-2 mm diameter 
 
Inoculate each selected colony into LAIA slant (53), Christensen's urea agar plate or slant, 
and bile esculin agar plate or slant by stabbing with inoculation needle. Incubate 48 h at RT. 
Isolates giving alkaline slant and acid butt, no gas and no H2S (KA− −) reaction in LAIA, 
which are also urease-positive, are presumptive Yersinia. Discard cultures that produce H2S 
and/or any gas in LAIA or are urease-negative. Give preference to typical isolates that fail 







o Y. enterocolitica (left) = K A − − 
o Salmonella (right) = K K + − 
 
  
Christensen's Urea agar 
o Y. ent. = pink color (urease postitive) 
o E. coli = no color (urease negative) 
 
  
Bile Esculin agar 
o Y. ent. (except biotype 1A) are 
esculin negative(absence of black 
color) 







Using growth from LAIA slant, streak culture to one plate of TSAYE and incubate at RT. 
Use growth on AEY to check culture purity, lipase reaction (at 2-5 days), oxidase test, 
Gram stain, and inoculum for biochemical tests. From colonies on TSAYE, inoculate the 
following biochemical test media and incubate all at RT for 3 days (except one motility test 
medium and one MR-VP broth, which are incubated at 35-37°C for 24 h). 
1. Decarboxylase basal medium (Falkow) (M44), supplemented with each of 0.5% lysine, 
arginine, or ornithine; overlay with sterile mineral oil 
2. Phenylalanine deaminase agar (M123) 
3. Motility test medium (semisolid) (M103), 22-26°C and 35-37°C 
Motility Test Medium with TTC 
 Y. ent. are motile at 
25°C (2 left tubes) 
and non-motile at 
35°C ( 2 right tubes) 
 
4. Tryptone broth (M164) 
5. Indole test (see instructions at end of chapter) 
6. MR-VP broth (M104). RT for autoagglutination test (see H1, below), followed by V-P 
test (48 h) (see instructions at end of chapter); 35-37°C for autoagglutination test 
(see H-1) 
7. Bromcresol purple broth (M26) with 0.5% of the following filter-sterilized 
carbohydrates: mannitol, sorbitol, cellobiose, adonitol, inositol, sucrose, rhamnose, 
raffinose, melibiose, salicin, trehalose, and xylose 
8. Simmons citrate agar (M138) 
9. Veal infusion broth (M173) 
10. Use API 20E system or Vitek GNI for biochemical identification of Yersinia. Follow 
manufacturer's instructions. These systems are generally reliable to identify Yersinia to 
genus level but are generally unreliable in identification ofYersinia to species level (3, 
32). Use conventional biochemical tests for speciation and biotyping of presumptive 
virulent isolates. Biochemical tests that are important for speciation within the 
genus Yersinia are fermentation of sucrose, rhamnose, raffinose and melibiose and the 
utilization of citrate (Table 1). Biochemical tests important for biotyping are 
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fermentation of salicin, xylose and trehalose along with VP reaction, lipase, esculinase, 
-D-Glucosidase, and pyrazinamidase (Table 2). 
11. Pyrazinamidase agar slants (48 h) (see instructions at end of chapter) 
12. -D-glucosidase test (30°C, 24 h) (see instructions at end of chapter) 
13. Lipase test. When grown on agar media containing egg yolk such as Anaerobic egg 
yolk agar, colonies may exhibit lipase activity. A positive reaction is indicated by oily, 
iridescent, pearl-like colony surrounded by precipitation ring and outer clearing zone. 
B. Interpretation 
Yersinia are oxidase-negative, Gram-negative rods. Use Tables 1 and 2 to identify species 
and biotype of Yersiniaisolates. Currently only strains of Y. enterocolitica biotypes 1B, 2, 3, 
4, and 5 are known to be pathogenic. These biotypes and Y. enterocolitica biotype 6 and Y. 
kristensenii do not rapidly (within 24 h) hydrolyze esculin or ferment salicin(Tables 1 and 
2). However, Y. enterocolitica biotype 6 and Y. kristensenii are relatively rare; they can be 
distinguished by failure to ferment sucrose, and they are pyrazinamidase-positive (28). 
Hold Y. enterocolitica isolates which are within biotypes 1B, 2, 3, 4, and 5 for further 
pathogenicity tests. 
C. Pathogenicity testing 
1. Autoagglutination test. The MR-VP tube incubated at RT for 24 h should show some 
turbidity from bacterial growth. The 35-37°C MR-VP should show agglutination 
(clumping) of bacteria along walls and/or bottom of tube with clear supernatant fluid. 
Isolates giving this result are presumptive positive for the virulence plasmid. Any other 
pattern for autoagglutination at these two temperatures is considered negative. 
MRVP Agglutination Test 
 When grown in MRVP 
broth at 25° C, pathogenic Y. 
ent.displays diffuse growth 
(left tube) but at 35°C cells 
agglutinate and settles to the 
bottom (right tube) 
 
2. Freezing cultures. Plasmids that determine traits related to pathogenicity 
of Yersinia can be spontaneously lost during culture above 30°C or with lengthy 
culture and passage below 30°C in the laboratory. It is important, therefore, to 
immediately freeze presumptive positive cultures to protect plasmid content. Inoculate 
into veal infusion broth and incubate 48 h at RT. Add 10% sterile glycerol (e.g., 0.3 ml 
in 3 ml veal infusion broth) and freeze immediately. Storage at -70°C is recommended. 
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3. Low calcium response Congo Red agarose virulence test. Inoculate test organism 
into BHI broth. Incubate overnight at 25-27°C. Make decimal dilutions in physiologic 
saline to obtain 1,000 cells/ml. Spread-plate 0.1 ml of appropriate dilution on each of 
two Congo Red agarose plates. Incubate one at 35°C and one at 25°C. Examine at 24 
and 48 h. Presumptive plasmid-bearing Y. enterocolitica will appear as pinpoint, 
round, convex, red, opaque colonies. Plasmidless Y. enterocolitica will appear as large, 
irregular, flat, translucent colonies. 
Y. enterocolitica on CRBHO After 24h at 35° C 
 Plasmid bearing Y. ent. colonies are 
pinpoint convex, red, opaque. 
 Plasmidless colonies are large, irregular, 




4. Intraperitoneal infection of adult mice pretreated with iron dextran and 
desferrioxamine B. A positive result from any of the in vitro pathogenicity tests (H, 1-
3 above) is strong evidence of pathogenicity. These results may be confirmed by a 
biological test using the i.p. infection of adult mice which have been pretreated with 
iron dextran and the iron sequestering siderophore, desferrioxamine B. This test is 
described elsewhere in detail (13, 53) and is omitted here for brevity and because few 
labs have the facilities to perform bioassays. 
5. Invasiveness. An in vitro HeLa cell assay is available for screening Yersinia isolates 
for invasive potential (33, 34). Acridine orange is used to stain infected HeLa cell 
monolayers, which are then examined under fluorescence microscope for the presence 
of intracellular Yersinia (33, 34). This in vitro staining technique can be used to 
determine invasiveness in both Y. enterocolitica and Y. pseudotuberculosis (16). 
D. Interpretation 
A positive reaction for any of the pathogenicity tests in H, 1-4 above can be taken as 
evidence of potential pathogenicity for a Y. enterocolitica or Y. pseudotuberculosis isolated 
strain. 
E. Yersinia pseudotuberculosis 
Generally, all Y. pseudotuberculosis strains are biochemically homogeneous except for 
production of acid from melibiose, raffinose, and salicin. Y. pseudotuberculosis heat-stable 
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somatic antigens are also used to subgroup the species. At present there are six serogroups 
represented by Roman numerals I-VI. Serogroups I, II, III, and IV have subtypes, but 
antiserum to one serogroup type will cross-react with the subtype strain and vice versa. 
Strains belonging to serogroups II and III are lethal when fed to adult mice even though 
these strains do not elaborate lipase. HeLa cell-invasive strains are esculin-positive, which 
is contrary to findings with Y. enterocolitica. Y. pseudotuberculosis strains harbor a 41-48 
Mdal plasmid and will autoagglutinate at 37°C. Association of yersiniosis in humans with 
the presence of a plasmid has been established (38). 
1. Enrichment. Aseptically weigh 25 g sample into 225 ml PMP broth (17). Homogenize 
for 30 s and incubate at 4°C for 3 weeks. At 1, 2, and 3 weeks, mix enrichment well. 
Transfer 0.1 ml enrichment to 1 ml 0.5% KOH in 0.5% NaCl and mix for 5-10 s. 
Successively streak one loopful to MacConkey agar plate and one loopful to CIN agar 
plate. Streak one additional loopful directly from enrichment broth to one MacConkey 
and one CIN agar plate. Incubate agars at RT. 
2. Isolation and identification. Continue as in E-H, above, noting biochemical 
differences (Table 1). Notably, Y. pseudotuberculosis strains are ornithine-, sorbitol-, 
and sucrose-negative. 
 
a+ = positive after 3 days at RT, (+) = positive after 7 days at RT. 
b Some strains of Y. intermedia are negative for either Simmons citrate, rhamnose, and melibiose, 
or raffinose and Simmons citrate. 
c Some biotype 5 strains are negative. 
 
a Based on Wauters (51). 
b ( ) = Delayed reaction; V = variable reactions. 
c Biotype of serotype O:3 found in Japan. 
Instructions for Yersinia Identification Tests 
Phenylalanine deaminase agar test: Add 2-3 drops 10% ferric chloride solution to growth on 
agar slant. Development of green color is positive test. 
Indole test: Add 0.2-0.3 ml Kovacs' reagent. Development of deep red color on surface of broth 
is positive test. 
V-P test: Add 0.6 ml alpha-naphthol and shake well. Add 0.2 ml 40% KOH solution with 
creatine and shake. Read results after 4 h. Development of pink-to-ruby red color in medium is 
positive test. 
Pyrazinamidase test: After growth of culture on slanted pyrazinamidase agar at RT, flood 1 ml 
of 1% freshly prepared ferrous ammonium sulfate over slant. Development of pink color within 





 Flood 1ml of 1% freshly prepared ferrous 
ammonium sulfate   
over slant. Pink color within 15 min is + 
 (right 2 test tubes= positive, left 2 tubes = 
negative). 
 
Beta-D-Glucosidase test: Add 0.1 g 4-nitrophenyl-beta-D-glucopyranoside to 100 ml 0.666 M 
NaH2PO4 (pH 6). Dissolve; filter-sterilize. Emulsify culture in physiologic saline to McFarland 
Turbidity Standard No. 3. Add 0.75 ml of culture to 0.25 ml of test medium. Incubate at 30°C 






Staphylococcus aureus Procedure 
Direct Plate Count Method 
This method is suitable for the analysis of foods in which more than 100 S. aureus cells/g may be 
expected. It conforms to the method in ref. 1. 
A. Equipment and materials 
1. Same basic equipment as for conventional plate count (Chapter 3). 
2. Drying cabinet or incubator for drying surface of agar plates 
3. Sterile bent glass streaking rods, hockey stick or hoe-shaped, with fire-polished ends, 
3-4 mm diameter, 15-20 cm long, with an angled spreading surface 45-55 mm long 
B. Media and reagents 
1. Baird-Parker medium (M17) 
2. Trypticase (tryptic) soy agar (TSA) (M152) 
3. Brain heart infusion (BHI) broth (M24) 
4. Coagulase plasma (rabbit) with EDTA 
5. Toluidine blue-DNA agar (M148) 
6. Lysostaphin (Schwartz-Mann, Mountain View Ave., Orangeburg, NY 10962) 
7. Tryptone yeast extract agar (M165) 
8. Paraffin oil, sterile 
9. 0.02 M phosphate-saline buffer (R61), containing 1% NaCl 
10. Catalase test (R12) 
C. Preparation of sample (see Chapter 1). 
D. Isolation and enumeration of S. aureus 
1. For each dilution to be plated, aseptically transfer 1 ml sample suspension to 3 plates 
of Baird-Parker agar, distributing 1 ml of inoculum equitably to 3 plates (e.g., 0.4 ml, 
0.3 ml, and 0.3 ml). Spread inoculum over surface of agar plate, using sterile bent glass 
streaking rod. Retain plates in upright position until inoculum is absorbed by agar 
(about 10 min on properly dried plates). If inoculum is not readily adsorbed, place 
plates upright in incubator for about 1 h. Invert plates and incubate 45-48 h at 35°C. 
Select plates containing 20-200 colonies, unless only plates at lower dilutions (>200 
colonies) have colonies with typical appearance of S. aureus. Colonies of S. aureus are 
circular, smooth, convex, moist, 2-3 mm in diameter on uncrowded plates, gray to jet-
black, frequently with light-colored (off-white) margin, surrounded by opaque zone 
and frequently with an outer clear zone; colonies have buttery to gummy consistency 
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when touched with inoculating needle. Occasionally from various foods and dairy 
products, nonlipolytic strains of similar appearance may be encountered, except that 
surrounding opaque and clear zones are absent. Strains isolated from frozen or 
desiccated foods that have been stored for extended periods frequently develop less 
black coloration than typical colonies and may have rough appearance and dry texture. 
2. Count and record colonies. If several types of colonies are observed which appear to 
be S. aureus on selected plates, count number of colonies of each type and record 
counts separately. When plates of the lowest dilution contain <20 colonies, these may 
be used. If plates containing >200 colonies have colonies with the typical appearance 
of S. aureus and typical colonies do not appear at higher dilutions, use these plates for 
the enumeration of S. aureus, but do not count nontypical colonies. Select > 1 colony 
of each type counted and test for coagulase production. Add number of colonies on 
triplicate plates represented by colonies giving positive coagulase test and multiply by 
the sample dilution factor. Report this number as number of S. aureus/g of food tested. 
E. Coagulase test 
Transfer suspect S. aureus colonies into small tubes containing 0.2-0.3 ml BHI broth and 
emulsify thoroughly. Inoculate agar slant of suitable maintenance medium, e.g., TSA, with 
loopful of BHI suspension. Incubate BHI culture suspension and slants 18-24 h at 35°C. 
Retain slant cultures at room temperature for ancillary or repeat tests in case coagulase test 
results are questionable. Add 0.5 ml reconstituted coagulase plasma with EDTA (B-4, 
above) to the BHI culture and mix thoroughly. Incubate at 35°C and examine periodically 
over 6 h period for clot formation. Only firm and complete clot that stays in place when 
tube is tilted or inverted is considered positive for S. aureus. Partial clotting, formerly 2+ 
and 3+ coagulase reactions, must be tested further (4). Test known positive and negative 
cultures simultaneously with suspect cultures of unknown coagulase activity. Stain all 
suspect cultures with Gram reagent and observe microscopically. A latex agglutination test 
(AUREUS TESTTM, Trisum Corp., Taipei, Taiwan) may be substituted for the coagulase 
test if a more rapid procedure is desired. 
F. Ancillary tests 
1. Catalase test. Use growth from TSA slant for catalase test on glass slide or spot plate, 
and illuminate properly to observe production of gas bubbles. 
2. Anaerobic utilization of glucose. Inoculate tube of carbohydrate fermentation medium 
containing glucose (0.5%). Immediately inoculate each tube heavily with wire loop. 
Make certain inoculum reaches bottom of tube. Cover surface of agar with layer of 
sterile paraffin oil at least 25 mm thick. Incubate 5 days at 37°C. Acid is produced 
anaerobically if indicator changes to yellow throughout tube, indicating presence 
of S. aureus. Run controls simultaneously (positive and negative cultures and medium 
controls). 
3. Anaerobic utilization of mannitol. Repeat 2, above, using mannitol as carbohydrate in 




4. Lysostaphin sensitivity. Transfer isolated colony from agar plate with inoculating loop 
to 0.2 ml phosphate-saline buffer, and emulsify. Transfer half of suspended cells to 
another tube (13 x 100 mm) and mix with 0.1 ml phosphate-saline buffer as control. 
Add 0.1 ml lysostaphin (dissolved in 0.02 M phosphate-saline buffer containing 1% 
NaCl) to original tube for concentration of 25 µg lysostaphin/ml. Incubate both tubes 
at 35°C for not more than 2 h. If turbidity clears in test mixture, test is considered 
positive. If clearing has not occurred in 2 h, test is negative. S. aureus is generally 
positive. 
5. Thermostable nuclease production. This test is claimed to be as specific as the 
coagulase test but less subjective, because it involves a color change from blue to 
bright pink. It is not a substitute for the coagulase test but rather is a supportive test, 
particularly for 2+ coagulase reactions. Prepare microslides by spreading 3 ml 
toluidine blue-deoxyribonucleic acid agar on the surface of each microscope slide. 
When agar has solidified, cut 2 mm diameter wells (10-12 per slide) in agar and 
remove agar plug by aspiration. Add about 0.01 ml of heated sample (15 min in boiling 
water bath) of broth cultures used for coagulase test to well on prepared slide. Incubate 
slides in moist chamber 4 h at 35°C. Development of bright pink halo extending at 
least 1 mm from periphery of well indicates a positive reaction. 
G. Some typical characteristics of 2 species of staphylococci and the micrococci, which may be 
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5B.1 Introduction  
Shiga toxin-producing Escherichia coli strains (STEC) of various serotypes have become an 
increasing public health concern since E. coli O157:H7 was first identified in 1982. STEC has 
been implicated in numerous outbreaks including development of hemolytic uremic syndrome 
(HUS) in some patients. Although E. coli O157:H7 has been most commonly identified as the 
cause of STEC infection, isolation of non-O157 STEC strains from clinical cases, outbreaks and 
environmental sources has been increasing (Posse et al., 2008). A study at the Centers for 
Disease Control and Prevention showed that from 1983-2002 approximately 70% of non-O157 
STEC infections in the United States were caused by strains from one of six major serogroups, 
including O26, O45, O103, O111, O121 and O145 (Brooks et al., 2005). Virulence factors for 
non-O157 STEC include, but are not limited to, production of the shiga-like toxins 1 and/or 2 
(Stx1, Stx2) and intimin (eae). Cattle and other ruminants appear to be the main reservoir of non-
O157 STEC, as well as the O157:H7 serotype (Arthur et al., 2002). With carriage rates of non-
O157 STEC in cattle being a public health concern, a method was devised to detect and isolate 
the six major non-O157 STEC serogroups (O26, O45, O103, O111, O121 and O145) in ground 
-time PCR Screening Assay for stx and eae detects the presence of the 
shiga toxin (stx) and intimin (eae) genes. Note that while this assay detects shiga toxin gene 
-time PCR 
assays, STEC Suite Panel 1 and Panel 2, are used to identify genes within the O antigen gene 
cluster specific for each serogroup. Cultural isolation of non-O157 STEC from screenpositive 
enrichments (positive for stx, eae and top six O antigen gene cluster) proceeds using 
immunomagnetic separation (IMS) beads coated with serogroup-specific antibodies followed by 
plating onto mRBA. A post-IMS acid treatment step is performed to help reduce background 
microflora that grow on mRBA. Many strains of STEC have been reported to have acid tolerance 
at pH 2 while competitor organisms show pH sensitivity (Grant, 2004; Bagwhat et al., 2005). 
Colonies on mRBA are tested for the presence of O antigens specific for the top six STEC 
serogroups using an agglutination test. Agglutination positive colonies are then streaked onto 
tryptic soy agar with 5% sheep blood (SBA) for -time PCR assays 
and biochemical identification.  
 
5B.2 Safety Precautions 
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 Similar to E. coli O157:H7, non-O157 STEC serotypes are human pathogens with a low 
infectious dose. The use of gloves, protective laboratory coats and eye protection is for all post 
enrichment viable culture work. Work surfaces must be disinfected prior to and immediately 
after use. Laboratory personnel must abide by CDC guidelines for manipulating Biosafety Class 
II pathogens. A Class II laminar flow biosafety cabinet is recommended for activities with 
potential for producing aerosols of pathogens. All available Safety Data Sheets (SDS) shall be 
obtained from the manufacturer for the media, chemicals, reagents and microorganisms used in 
the analysis. The personnel who will handle the materials should read all SDS.  
5B.3 Equipment, Reagents and Media 
 5B.3.1 Equipment and Materials  
a. Balance, sensitivity ± 0.1 g b. Blending/mixing equipment: Paddle blender, Sterile Osterizer-
type blender with sterilized cutting assemblies, and blender jars or equivalent and adapters for 
use with Mason jars c. Sterile plain, clear polypropylene bags (ca. 24" x 30 - 36"), or Whirl-
(Qualicon or equivalent). f. Cell lysis tube cooling block (Qualicon or equivalent) held at 5 ± 3ºC 
g. PCR cooling block (Qualicon or equivalent) held at 5 ± 3ºC h. Heating block set at 37 ± 2ºC i. 
Heating block set at 95 ± γºC j. Repeating pipettor to deliver β00 ± β0 μl and sterile tips k. 
Pipettor to deliver β0 ± 1μl, and sterile disposable filtered tips l. Pipettor to deliver 150 ± 15 μl, 
and sterile disposable filtered tips m. Eight-channel pipettor to deliver γ0 ± γ μl, and sterile 
disposable tips n. Pipettor to deliver 5 ± 1 μl, and sterile disposable tips. o. 1β X 75 mm Falcon 
352063, or equivalent, tubes p. Cell lysis tubes and caps, cell lysis tube rack and box 
-3120-5 or equivalent) q. Pipettor or pipettes to 
–time PCR 
Assay STEC Screening (Part # D14642964) held at 5 ± 3ºC t. BAX® System Real–time PCR 
Assay STEC Panel 1 (Part # D14642970) held at 5 ± 3ºC u. BAX® System Real–time PCR 
Assay STEC Panel 2 (Part # D14642987) held at 5 ± 3ºC v. Micropipettors for culture plating to 
deliver volumes ranging from 15-1000 μl with sterile disposable filtered tips w. VITEK® β 
system x. GN cards for VITEK® 2 system (bioMerieux Vitek, Inc.) y. Heating block (95-99°C) 
or thermocycler for DNA preparation step) z. Vortexer aa. Centrifuge that holds microcentrifuge 
tubes and is capable of speeds up to 16,000 x g bb. Centrifuge plate adapter for the centrifugation 
of 96-well PCR plates cc. Disposable, sterile pipettes for volumes 1.0 ml and for 5.0 ml. dd. 
Sterile, inoculating loops, “hockey sticks” or spreaders, and needles ee. Rotating tube agitator 
with clips to hold microcentrifuge tubes ff. Sterile, disposable 12 x 75 mm polypropylene or 
polystyrene tubes gg. Sterile microcentrifuge tubes (1.5 - 2.0 ml) hh. Sterile 50 ml conical tubes 
ii. Sterile 40 μm Cell Strainer jj. MACS® Large Cell Separation Columns (Miltenyi Biotec # 
422-02) kk. OctoMACS® Separation Magnet (Miltenyi Biotec # 421-09) ll. Multistand to 
support OctoMACS® Separation Magnet (Miltenyi Biotec # 423-03) mm. Tray, autoclavable, 
approximately 130 mm x 83 mm for use with the OctoMACS® nn. Sterile filter or non-filter 
bags oo. Optical density reader 
  
5B.3.2 Media and Reagents 
 a. Modified Tryptone Soya Broth (mTSB) b. Modified Rainbow Agar (mRBA) [Rainbow® 
Agar O157 Biolog Inc., Hayward California, 94545] containing 5.0 mg/L sodium novobiocin, 
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0.05 mg/L cefixime trihydrate and 0.15 mg/L potassium tellurite c. Cefixime trihydrate d. 
Tryptic soy agar with 5% sheep blood [Sheep Blood Agar (SBA)] e. 1.0 N Hydrochloric Acid 
(HCl) f. Physiological saline solution (0.85% NaCl) g. 1X Tris-EDTA (TE) Buffer h. E Buffer, 
approximately 7 ml per sample (See Media and Reagents Appendix 1, Buffered Peptone Water, 
Bovine Albumin Sigma and Tween-20®) i. Disinfectant (Lysol® I. C., 2.0%) j. Romer Labs 
RapidChek® CONFIRM STEC Immunomagnetic Separation (IMS) Kit with anti-O26 antibody-
coated paramagnetic beads, anti-O103 antibody-coated paramagnetic beads, anti-O111 antibody-
coated paramagnetic beads, anti-O145 antibody-coated paramagnetic beads, anti-O45 
antibodycoated paramagnetic beads, and anti-O121 antibody-coated paramagnetic beads k. 
RNase free, DNase free PCR Certified Water l. Biochemical test kit and system, GN cards 
(VITEK® 2 system, bioMerieux Vitek, Inc., 595 Anglum Drive, Hazelwood, MO 63042-2395) 
m. Abraxis non-O157 STEC Latex Agglutination Test (LAT) Kits or equivalent specific for 
serogroups O26, O45, O103, O111, O121 and O145  
5B.4 Quality Control  
5B.4.1 General 
 a. Unless otherwise stated, weight and volume ranges and minutes have a tolerance of ±2%. b. 
All media, plates and buffers shall be warmed to 18-35°C prior to use. c. The top six non-O157 
STEC control strains shall meet the following genetic characteristics: stx+ and eae+. Such strains 
can be obtained through reference culture collection centers including but not limited to the 
American Type Culture Collection (ATCC), the STEC Center at The Michigan State University 
and the E. coli Reference Center at The Pennsylvania State University. Non-O157 strains (stx+, 
eae+) must be used by FSIS Laboratories to prepare the DNA template positive PCR control. 
However, for safety considerations, toxin-attenuated or toxin-negative strains that have an 
appearance on mRBA typical of the non-O157 STEC may be used as controls on plating media 
for serological agglutination testing. In the absence of a positive test sample, control cultures 
may be terminated at the same point as the sample analyses. The following non-O157 STEC 
control strains shall be used when stated in the method: i. E. coli O26, which shall be stx positive 
and eae positive ii. E. coli O45, which shall be stx positive and eae positive iii. E. coli O103, 
which shall be stx positive and eae positive iv. E. coli O111, which shall be stx positive and eae 
positive v. E. coli O121, which shall be stx positive and eae positive vi. E. coli O145, which shall 
be stx positive and eae positive Note: In the absence of a positive test sample, control cultures 
may be terminated at the same point as the sample analyses.  
5B.4.2 Sample Enrichment Controls  
Include with each sample batch, a positive growth control (E. coli O157:H7 strain 465-97 or 
other reference strain that is stx-, eae+) inoculated into a meat matrix free of the target analyte, 
and an uninoculated media (mTSB) control.  
 
5B.4.3 BAX  Real-time PCR Controls  
a. stx/eae screen PCR • β0 µl enrichment from bioluminescent E. coli O157:H7 strain 465-97 
(growth control) • DNA template (5 µl) from a cocktail of top six STEC cultures (PCR positive 
control) • Uninoculated mTSB medium (β0 µl) b. Serogroup-specific screen PCR (Panel 1 and 
Panel β) • DNA template (5 µl) from a cocktail of top six STEC cultures (PCR positive control) • 
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Uninoculated mTSB medium (20 µl) c. Optional stx/eae presumptive PCR / stx/eae confirmatory 
PCR • DNA template (5 µl) from a cocktail of top six STEC cultures (PCR positive control) d. 
Optional serogroup-specific presumptive PCR (Panel 1 and Panel 2) / Serogroup-specific 
confirmatory PCR (Panel 1 and Panel β) • DNA template (5 µl) from a cocktail of top six STEC 
cultures (PCR positive control) To prepare PCR positive control DNA template, FSIS 
laboratories shall grow the top six STEC cultures on SBA and incubate at 35±2°C for 16-24 h. 
Colonies shall be used to create a culture suspension in PCR certified water corresponding to 
approximately 109 CFU/ ml. In one tube, 1.0 ml from each suspension shall be added to 4.0 ml 
of PCR certified water to create a 10.0 ml cocktail of all six strains. This will provide 
approximately a 108 CFU/ml cocktail using each strain. One hundred microliter aliquots of the 
suspension are then transferred to PCR tubes or microcentrifuge tubes and heated at 95-99°C for 
10 minutes on a thermocycler or heating block. The tubes shall be centrifuged at 10,000 x g for 3 
minutes to pellet cellular debris. The supernatant shall be used as the PCR positive control for all 
PCR assays. DNA control template can be prepared as a batch, transferred to smaller volume 
tubes, and stored at ≤ -20°C for 1 year.  
5B.4.4 IMS Plating Controls 
Streak an isolate from the serogroup(s) of interest (based on serogroup-specific PCR results) 
onto mRBA and incubate along with the samples that have been treated with the IMS procedure.  
5B.5 Sample Preparation and Primary Enrichment 
Note: Disinfect the sample package prior to opening. a. For raw beef, raw beef mixes, beef trim, 
and trim components, place the 325 ± 32.5g test portion per submitted sample into the sterile bag 
with mesh filter. Ensure that the entire test portion is on the same side of the mesh filter. Add 
975 ± 19.5 ml of mTSB to the test portion to provide a 1:4 dilution (one portion of product to 
three portions of broth). Pummel, blend or hand massage until well mixed. Incubate the test 
portion and the enrichment media at 42±1°C for 15-24 hours. Each group of samples should 
include a positive control enrichment (E. coli O157:H7 strain 465-97) and an uninoculated 
enrichment medium control. b. For environmental sponges and carcass sponges with 10 ml of 
buffer, add 50 ± 5 ml of mTSB broth. For carcass sponges with more buffer, use a 1:6 ratio of 
mTSB (for example, a swab with 25 ml of buffer will use 125 ml of enrichment broth) to each 
bagged sponge sample. Pummel, blend or hand massage until well mixed.  
-time PCR 
 5B.6.1 Procedure 
Following incubation, perform the rapid screen using 20 µl of mTSB sample enrichment for all 
Guide for preparing reagents, performing the STEC screening PCR, Panel 1 and Panel 2 PCR, 
and interpreting results, if applicable. The real-time PCR assay developed for the ABI 7500 
FAST is an alternative screen described in MLG 5B Appendices 1 and 3. Following incubation 
of raw beef mixes containing poultry, a centrifuge step must be performed prior to BAX® 
screening: • Dispense β00 ± β0 μl lysis reagent to each cell lysis tube. • Heat the filled lysis tubes 
for 20 ±1 minute at 37 ± 2°C. Aseptically transfer 1 ml of the poultry mix enrichment sample to 
a sterile 1.5 ml microcentrifuge tube. • Centrifuge at a setting of 1,500 x g for 1 minute (at speed) 
to pellet large debris. Supernatant will still not be clear at this low speed but should no longer 
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have large particles of meat suspended. • Transfer the supernatant to a new sterile 1.5 ml 
microcentrifuge tube. It is essential to ensure that none of the pelleted debris is carried over with 
the supernatant. • Centrifuge supernatant at 10,000 x g for 5 minutes. • Discard the supernatant 
from the centrifuge tube, leaving a little of the supernatant if necessary so the pellet is not 
disturbed during this step. • Suspend the pellet in 100 μl of PCR grade water either by vortexing 
or using the pipet tip. • Add 5 µl of the suspension directly to the pre-heated lysis buffer that was 
prepared during the initial steps. • Heat the inoculated lysis tubes for 10 ± 1 minute at 95 ± γ °C. 
Perform remainder of the PCR test according to manufacturer’s instructions.  
5B.6.2 Interpretation of Results 
creening PCR (stx, eae) shall be reported as 
negative. Samples that test positive for the STEC screening PCR (stx, eae) will be further 
remain chilled at 2-8°C until loaded into the instrument. Remaining lysate may be sealed and 
stored for additional testing with other BAX® System STEC suite assays. Lysates may be stored 
at 2-8°C for up to 7 days or at -20 ± 3°C for up to 14 days. Note: For Panel 1 and Panel 2 results, 
each well must be clicked individually and the results for each individual O-group should be 
recorded. b. Samples that test positive for the STEC screening PCR (stx, eae) but negative for 
both Panel 1 and Panel 2 shall be reported as negative. If any of the Ogroups from Panel 1 or 
Panel 2 are positive, the sample shall be reported as a potential positive. Proceed with the 
isolation procedure as described in Section 5B.7. c. Samples that are indeterminate or have an 
g PCR (stx, eae) should be tested again using STEC 
screening PCR and Panels 1 and 2 assays using either the same lysate or preparing new lysate 
have an invalid result on one or both Panel 1 and 2 assays proceed to Section 5B.7 Isolation 
Procedure and analyze for the indeterminate O groups. Alternatively, the laboratory may review 
the cause and perform a correction. Based on the findings, the laboratory may: • repeat the 
-negative, indeterminate, or 
has a signal-error result, the entire batch of samples is affected and a review of the cause and a 
analyze all of the samples culturally. If reanalysis of a sample with indeterminate or invalid 
fresh analytical portions from the sample reserve, or discard the sample.  
5B.7 Isolation Procedure 
 Samples that are potentially positive by PCR screen results shall be plated onto mRBA 
following IMS. In the isolation procedure, IMS beads shall be used for the specific serogroup 
identified by the serogroup PCR reaction (i.e. anti-O26 will be used for samples with screen 
results positive for O26, anti-O45 for O45 PCR positive reactions, anti-O103 for O103 PCR 
positive reactions or anti-O121 for O121 PCR positive reactions, anti-O111 for O111 PCR 
positive reactions and/or anti-O145 for O145 PCR positive reactions). A postIMS acid treatment 
step has been added to reduce background flora on the mRBA plate. Following the one hour acid 
treatment step, samples are diluted 1:1 with E-buffer and 0.1 ml is spread plated onto mRBA. 
Additionally, the suspension is diluted 1:10 and 0.1 ml is spread plated onto mRBA. 
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 5B.7.1 Immunomagnetic Separation and Culture Plating 
a. Remove mRBA plates from 2-8°C storage, allowing 4 plates for each screenpositive culture 
and one plate for each serogroup control strain. Be sure that plates have no visible surface 
moisture at the time of use. If necessary, dry plates (e.g. for up to 30 minutes in a laminar flow 
hood with the lids removed) prior to use. Dried plates that are not used should be labeled "dried", 
placed in bags and returned to 2-8°C. b. For each screen-positive culture, label two sterile 
microcentrifuge tubes (for step d and step m), one 50 ml conical centrifuge tube (for step c) and 
four 12 x 75 mm capped tubes (for steps i and j). For three of the 12 x 75 mm tubes, add 0.9 ml 
E-Buffer and label one tube as 1:10, one tube as 1:100 and one tube as acid 1:10. c. Sample 
preparation from overnight enrichment: For each serogroup that the sample is positive, transfer 
approximately 2-5 ml from overnight enrichment through a 40 μm Cell Strainer into a 50 ml 
conical centrifuge tubes. d. Binding of paramagnetic antibody beads to specific serogroup: 
Transfer 50.0 μl (or volume recommended by the manufacturer) of appropriate immunomagnetic 
capture beads determined by the serogroup PCR screen results (O26, O45, O103, O111, O121 or 
O145) to a sterile, labeled microcentrifuge tube. Next, add 1 ml of enrichment filtrate to the 
appropriately labeled tube. e. Place the microcentrifuge tubes containing enrichments and 
capture beads on LabQuake® Agitator and rotate tubes for 15 minutes at 18-30°C (or time 
recommended by the manufacturer). f. For each sample, place one MACS® Large Cell 
Separation Columns onto the OctoMACS® Separation Magnet. Fill the tray below the separation 
magnet with disinfectant. Prime each separation column with at least 0.5 ml of Ebuffer and allow 
the liquid to pass completely through before adding sample. g. Binding of beads to magnetic 
columns: Once the liquid has passed through the column, add the 1.0 ml of enrichment plus IMS 
beads to each appropriately labeled column and allow liquid to completely pass through. h. Wash 
steps (4X): Add 1.0 ml of E-buffer to each column allowing the liquid to pass completely 
through. Repeat 3 more times for a total of 4 washes. i. Elution step: After the last wash has 
drained, remove the column from the OctoMACS® Magnet and insert the tip into an empty 
labeled 12 x 75 mm tube. Apply 1.0 ml of E Buffer to the column, and using the plunger 
supplied with the column, immediately flush out the beads into the tube. Use a smooth, steady 
motion to avoid splattering. Cap the tubes. Repeat this for each column. j. Make a 1:10 dilution 
of each treated bead suspension by adding 0.1 ml of the bead suspension to a 12 x 75 mm labeled 
tube containing 0.9 ml E-Buffer. Make a 1:100 dilution by adding 0.1 ml of the 1:10 dilution to a 
12 x 75 mm labeled tube containing 0.9 ml E Buffer. k. Vortex briefly to maintain beads in 
suspension and plate 0.1 ml from each tube (1:10 dilution and 1:100 dilutions) onto a labeled 
mRBA plates. Use a hockey stick or spreader to spread plate the beads, being careful not to 
spread the beads against the edge of the plate. l. As soon as there is no visible moisture on the 
agar surface, invert plates and incubate for 20-24 h at 35 ± 2°C. m. Acid Treatment: For each 
sample, transfer 450 µl of the undiluted bead suspension (MACS column eluant) to an empty 
labeled microcentrifuge tube. Add β5 μl of 1N hydrochloric acid (HCl) to this bead suspension 
and vortex briefly. This will bring the pH to 2.0-2.5 using E-buffer. n. Place the microcentrifuge 
tubes containing the acid treated suspension on a LabQuake® Agitator and rotate tubes for 1 
hour at 18-γ0°C temperature. o. After 1 hour, dilute the suspension by adding 475 μl of E-buffer. 
p. Vortex briefly to maintain beads in suspension and plate 0.1 ml of the neutralized suspension 
onto a labeled mRBA plate. Use a hockey stick or spreader to spread plate the beads, being 
careful not to spread the beads against the edge of the plate. q. Add 0.1 ml of the suspension to a 
labeled tube containing 0.9 ml E-buffer and vortex briefly. This shall represent a 1:10 dilution of 
the acid-treated cell suspension. Plate 0.1 ml of the diluted suspension onto an appropriately 
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labeled mRBA plate. r. As soon as there is no visible moisture on the agar surface, invert plates 
and incubate for 20-24 h at 35 ± 2°C.  
5B.8 Identification and Confirmation 
Following 20-24 h incubation of mRBA, plates will be examined for colonies that agglutinate 
with latex agglutination reagents specific for the serogroup of interest. Colony colors from 
representative strains of each serogroup are listed in MLG 5B Appendix 2 Morphologies of 
Representative Strains from Top Six non-O157 Shiga Toxin-Producing Escherichia coli (STEC) 
Grown on mRBA. However, the coloration of colonies described in MLG 5B Appendix 2 may 
vary based on proximity to other competitor colonies or medium discoloration due to competitor 
colony growth. Since the morphologies of the targeted STEC colonies may vary widely among 
strains and serogroups, test at least one colony from each identified colony morphology found on 
the mRBA plate. Samples that have no growth or only contain agglutination negative colonies on 
mRBA are negative for non-O157 STEC. Any sample with agglutination positive colonies for 
the serogroup of interest is a presumptive positive for non-O157 STEC. Agglutination positive 
colonies shall be streaked onto SBA for confirmation on the following day. Following a restreak 
of presumptive colonies and 16-24 h incubation of the SBA, agglutination-positive colonies shall 
-time PCR and biochemical identification. The confirmatory 
-time PCR shall include the Screening assay (stx and eae) and the O-group Panel 
which includes the serogroup that the colony had a positive agglutination reaction (i.e. Panel 1 
for O26, O111, O121, and Panel 2 for O45, O103, and O145). If no colony picks isolated from 
the mRBA confirm by PCR and VITEK® 2, the sample is negative for non-O157 STEC. If a 
FSIS Laboratory has confirmatory test results insufficient to allow identification (i.e. 
confirmatory PCR positive but biochemically negative), then the isolate is transferred to the 
Outbreaks Section of the Eastern Laboratory Microbiology Branch (OSEL), or current FSIS 
reference laboratory, for further testing prior to reporting.  
5B.8.1 Presumptive PCR Assay 
 A PCR test may be performed directly on agglutination positive colonies from the mRBA to 
verify presumptive positive colonies using the following procedure. The presumptive PCR assay 
is optional for non-FSIS laboratories. a. Transfer the remainder of an agglutination positive 
colony from the mRBA plate into 50 µl of Molecular Grade Water (for up to 5 colonies). b. Add 
5 µl from the 
95 ± 3o C for 10 ± 1 minute then cool for 5-30 minutes in cooling block. Add 30 µl of the lysate 
-time Screening assay (stx/eae) reaction tube and the appropriate Panel 
reaction tube each on a cooling block. Note: Each PCR assay shall include a positive control as 
described in Quality Control section 5B.4. c. The sample is considered negative if any of the 3 
PCR targets (stx, eae or serogroup) are negative. d. If an agglutination positive colony from 
mRBA is positive for O group, stx and eae targets, the sample is considered a presumptive 
positive for non-O157 STEC. Refer to section 5B.8.2 for confirmation of the isolates as non-
O157 STEC. e. From the previous suspension, streak SBA for isolation. Incubate inoculated 
SBA plates at 35 ± 2°C for 16-24 hours.  
5B.8.2 Serological Agglutination and Confirmation PCR Procedure 
a. Use an inoculating loop or needle to transfer a portion of an isolated colony from the mRBA 
plate to serological agglutination reagent. Follow manufacturer’s instructions on procedure and 
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interpretation. Control Reactions: A reference strain from the serogroup of interest plated on 
mRBA shall be used as the positive culture control. For presumptive PCR screen from colonies 
isolated on mRBA, refer to section 5B.8.2 Presumptive PCR Assay. b. Transfer the remainder of 
an agglutination positive colony from the mRBA plate onto SBA for further biochemical and 
genetic confirmation. Streak up to 5 agglutination positive colonies onto SBA plates. Incubate 
plates at 35 ± 2°C for 16-24 hours. c. Following SBA incubation, perform the agglutination test 
again on colonies from the SBA plate. d. To confirm agglutination-positive colonies using 
-time PCR, prepare a template by suspending an agglutination positive colony from 
BA
Note: Each PCR assay shall include a positive control as described in Quality Control section 
5B.4. f. Additionally, perform biochemical identification (VITEK® 2) on agglutination positive 
colonies from the incubated SBA. A positive isolate shall be identified biochemically as E. coli. 
-time PCR 
positive for stx, eae, and top six serogroup genes and biochemically identified as E. coli, the 
sample is positive for non-O157 STEC. h. If the isolate and any additional colony picks from 
-time PCR negative for stx, eae, top six 
serogroup genes, the sample is negative for non-O157 STEC.  
5B.9 Culture Storage 
For storage requirements of the fluorescent E. coli O157:H7 strain (FSIS culture # EC 465-97 or 
the currently designated control strain) refer to MLG 5 Detection, Isolation and Identification of 
Escherichia coli O157:H7 from Meat Products, Section 5.3.c. Store other "working" non-O157 
E. coli stock cultures on nutrient agar slants. Transfer stocks monthly onto duplicate nutrient agar 
slants, incubate overnight at 35± 2°C, and then store them at 2-8°C. Use one of the slants as the 
working culture. Use the other slant for subculturing to reduce the opportunity for contamination. 
For long term storage, freeze cultures using cryo-beads, i.e., Cryostor™ or lyophilize.  
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